<SEC-DOCUMENT>0001144204-14-049413.txt : 20140813
<SEC-HEADER>0001144204-14-049413.hdr.sgml : 20140813
<ACCEPTANCE-DATETIME>20140813170547
ACCESSION NUMBER:		0001144204-14-049413
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20140813
DATE AS OF CHANGE:		20140813
EFFECTIVENESS DATE:		20140813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-198121
		FILM NUMBER:		141038353

	BUSINESS ADDRESS:	
		STREET 1:		20 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
		BUSINESS PHONE:		240-268-2000

	MAIL ADDRESS:	
		STREET 1:		20 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>v386486_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
Commission on August 13, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNDER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">THE SECURITIES ACT OF 1933</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOVAVAX, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(State of incorporation)</I></P></TD>
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20 Firstfield Road,</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gaithersburg, Maryland 20878</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Address of principal executive offices)</I></P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>22-2816046</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(I.R.S. Employer Identification No.)</I></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Amended and Restated 2005 Stock
Incentive Plan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Full Title of the Plan)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>JOHN A. HERRMANN III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Vice President, General Counsel &amp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Novavax, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">20 Firstfield Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Gaithersburg, Maryland 20878</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">jherrmann@novavax.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(240) 268-2000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<I>Name, Address and Telephone Number,
Including Area Code, of Agent For Service</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">with copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PAUL M. KINSELLA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Ropes &amp; Gray LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">800 Boylston Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Boston, Massachusetts 02199-3600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">pkinsella@ropesgray.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(617) 951-7000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &ldquo;large accelerated
filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule&nbsp;12b-2 of the Exchange Act.
(Check one):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Large accelerated filer <FONT STYLE="font-family: Wingdings">o</FONT></FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Accelerated filer <FONT STYLE="font-family: Wingdings">&thorn;</FONT></FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Non-accelerated filer <FONT STYLE="font-family: Wingdings">o</FONT> </FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Smaller reporting company <FONT STYLE="font-family: Wingdings">o</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Do not check if a smaller<BR>
reporting company)</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">Proposed</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">Proposed</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">maximum</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">maximum</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">Title of</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">Amount to be</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">offering price</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">aggregate</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">Amount of</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">securities to be registered</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">registered</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">per share</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">offering price</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">registration fee</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 48%">Common Stock, $0.01 par value</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 10%; text-align: right">4,000,000</TD><TD NOWRAP STYLE="width: 1%; text-align: left">(1)</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left">$</TD><TD NOWRAP STYLE="width: 10%; text-align: right">4.26</TD><TD NOWRAP STYLE="width: 1%; text-align: left">(2)</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left">$</TD><TD NOWRAP STYLE="width: 10%; text-align: right">17,040,000</TD><TD NOWRAP STYLE="width: 1%; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; text-align: left">$</TD><TD NOWRAP STYLE="width: 10%; text-align: right">2,195</TD><TD NOWRAP STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Plus, pursuant to Rule&nbsp;416(a)&nbsp;under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), such
additional number of shares of Novavax, Inc. common stock as may be issued upon a stock split, stock dividend, or similar transaction.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Pursuant to Rules&nbsp;457(c)&nbsp;and 457(h)(1)&nbsp;under the Securities Act, the proposed maximum offering price per share
and the maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration
fee on the basis of the average of the high and low prices of Novavax, Inc. common stock as reported by The NASDAQ Global Select
Market on August 8, 2014, which were $4.37 and $4.14, respectively.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Explanatory Note</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant hereby increases the number of shares of its
common stock registered for issuance under its Amended and Restated 2005 Stock Incentive Plan (the &ldquo;Plan&rdquo;) by 4,000,000
shares. Pursuant to Instruction E to Form S-8, the Registrant incorporates by reference into this Registration Statement the entire
contents of the following Registration Statement on Form S-8 filed with the Securities and Exchange Commission (File No. 333-130990)
on January 12, 2006.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933,
the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8
and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the
city of Gaithersburg, state of Maryland on August 13, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">NOVAVAX, INC.</FONT><BR>
<FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 34%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;/s/ Stanley C. Erck</FONT></TD>
    <TD STYLE="width: 14%">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Stanley C. Erck</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">President and Chief Executive Officer&nbsp; and Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each person whose signature appears below constitutes and appoints
Stanley C. Erck, Barclay A. Phillips and John A. Herrmann III, and each of them singly, his true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution in each of them singly, for him and in his name, place and stead, and
in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement
on Form S-8 of Novavax, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with
the Securities and Exchange Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority
to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents
and purposes as he might or could do in person, hereby ratifying and confirming all that the attorneys-in-fact and agents or any
of each of them or their substitutes may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 25%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Signature</B> </FONT></TD>
    <TD NOWRAP STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B> </FONT></TD>
    <TD NOWRAP STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 25%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B> </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Stanley C. Erck</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer </FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Stanley C. Erck</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">and Director (Principal Executive Officer)</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Barclay A. Phillips</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Senior Vice President, Chief Financial Officer and Treasurer</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Barclay A. Phillips</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ James F. Young, Ph.D.</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors&nbsp; </FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">James F. Young, Ph.D.</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Richard H. Douglas</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director&nbsp; </FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Richard H. Douglas</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/Gary C. Evans</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Gary C. Evans</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Rajiv I. Modi, Ph.D.</FONT></TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Rajiv I. Modi, Ph.D</FONT></TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Michael A. McManus, Jr., J.D.</FONT></TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Michael A. McManus, Jr., J.D.</FONT></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: center"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEX OF EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 6%"><FONT STYLE="font-size: 10pt">Exhibit</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 93%; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Number</FONT></TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Description</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">4.1 </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Amended and Restated Certificate of Incorporation of Novavax, Inc., as amended by Certificates of Amendment dated December 18, 2000, July 8, 2004, May 13, 2009 and dated June 13, 2013&nbsp;&nbsp;(Incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, filed August 8, 2013)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Amended and Restated By-Laws of the Company (Incorporated by reference to Exhibit 3.2 to the Company&rsquo;s Annual Report on Form 10-K&nbsp;&nbsp;for the year ended December 31, 2012, filed March 12, 2013)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Opinion of Ropes &amp; Gray LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Novavax, Inc. Amended and Restated 2005 Stock Incentive Plan</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Consent of Ropes &amp; Gray LLP (included in Exhibit&nbsp;5.1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Consent of Grant Thornton LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">24*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Power of Attorney to file future amendments. Set forth on the signature page of this Registration Statement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*&#9;Filed herewith</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>v386486_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><img src="tex5-1logo.jpg"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">August 13, 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 350.65pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Novavax, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">20 Firstfield Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gaithersburg, Maryland 20878</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion is furnished to you in connection with a Registration
Statement on Form&nbsp;S-8 (the &ldquo;Registration Statement&rdquo;) filed on or about the date hereof with the Securities and
Exchange Commission under the Securities Act of 1933, as amended, for the registration of 4,000,000 shares of common stock, $0.01
par value (the &ldquo;Shares&rdquo;), of Novavax, Inc., a Delaware corporation (the &ldquo;Company&rdquo;).&nbsp; The Shares are
issuable under the Company&rsquo;s Amended and Restated 2005 Stock Incentive Plan (the &ldquo;Plan&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are familiar with the actions taken by the Company in connection
with the proposed issuance of the Shares.&nbsp; For purposes of our opinion, we have examined and relied upon such documents, records,
certificates, and other instruments as we have deemed necessary.&nbsp; The opinions expressed below are limited to the General
Corporation Law of the State of Delaware, including applicable provisions of the Delaware constitution and the reported cases interpreting
those laws, and we are expressing no opinion as to the effect of the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based on the foregoing, we are of the opinion that the Shares
have been duly authorized and, when the Shares have been issued and sold in accordance with the terms of the Plan, the Shares will
be validly issued, fully paid, and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the filing of this opinion as an exhibit
to the Registration Statement.&nbsp; Our consent shall not be deemed an admission that we are experts whose consent is required
under Section&nbsp;7 of the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Ropes &amp; Gray LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ropes&nbsp;&amp; Gray LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>v386486_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><img src="tex10-1logo.jpg"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOVAVAX, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR>
AMENDED AND RESTATED 2005 STOCK INCENTIVE PLAN<BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Adopted by the Board of Directors February
24, 2005; Approved by Stockholders Mary 4, 2005</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amended by the Board of Directors March
7, 2007; Approved by Stockholders June 20, 2007</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amended by the Board of Directors March
10, 2011; Approved by Stockholders June 15, 2011</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amended by the Board of Directors March
1, 2012; Approved by Stockholders June 11, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amended by the Board of Directors March
2, 2013; Approved by Stockholders June 13, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amended by the Board of Directors March
6, 2014; Approved by Stockholders June 12, 2014</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purpose</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The purpose of this plan (the &ldquo;<B><I>Plan</I></B>&rdquo;)
is to secure for Novavax, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;) and its stockholders the benefits arising from capital
stock ownership by employees, officers and directors of, and consultants or advisors to, the Company and its parent and subsidiary
corporations who are expected to contribute to the Company&rsquo;s future growth and success. Except where the context otherwise
requires, the term &ldquo;Company&rdquo; shall include the parent and all present and future subsidiaries of the Company as defined
in Sections 424(e) and 424(f) of the Internal Revenue Code of 1986, as amended or replaced from time to time (the &ldquo;<B><I>Code</I></B>&rdquo;);
(provided, however, that status as a &ldquo;parent&rdquo; or &ldquo;subsidiary&rdquo; corporation depends on satisfaction of the
criteria in Sections 424(e) and (f) as of the date on which such determination is being made, and does not necessarily continue
to exist merely because it did so as of the date of grant of an option or other award). Those provisions of the Plan which make
express reference to Section 422 shall apply only to Incentive Stock Options (as that term is defined in the Plan). The Plan is
being amended and restated effective January 1, 2008 to reflect the requirements of Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Type
of Stock Awards and Administration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Types
of Awards</U></I>. This Plan provides for the grant of stock options, restricted stock awards, stock appreciation rights (SARs),
and restricted stock units (RSUs) (collectively, these awards shall be referred to herein as &ldquo;<B><I>Stock Awards</I></B>&rdquo;).
Options granted pursuant to the Plan may be either incentive stock options (&ldquo;<B><I>Incentive Stock Options</I></B>&rdquo;)
meeting the requirements of Section 422 of the Code or non-statutory options which are not intended to meet the requirements of
Section 422 of the Code (&ldquo;<B><I>Non-Statutory Options</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Administration</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan will be administered by the Board of Directors of the Company, whose construction and interpretation of the terms and provisions
of the Plan shall be final and conclusive. The Board of Directors may in its sole discretion grant Stock Awards to purchase shares
of the Company&rsquo;s Common Stock, $.01 par value (&ldquo;<B><I>Common Stock</I></B>&rdquo;), and issue shares upon the receipt
or exercise of such Stock Awards as provided in the Plan. The Board shall have authority, subject to the express provisions of
the Plan, to construe the respective agreements under which Stock Awards are made and the Plan, to proscribe, amend and rescind
rules and regulations relating to the Plan, to determine the terms and provisions of the respective agreements, which need not
be identical, and to make all other determinations which are, in the judgment of the Board of Directors, necessary or desirable
for the administration of the Plan. The Board of Directors may correct any defect, supply any omission or reconcile any inconsistency
in the Plan or in any Stock Award agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect
and it shall be the sole and final judge of such expediency. No director or person acting pursuant to authority delegated by the
Board of Directors shall be liable for any action or determination under the Plan made in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors may, to the full extent permitted by or consistent with applicable laws or regulations and Section 3(b) of this
Plan delegate any or all of its powers under the Plan to a committee (the &ldquo;<B><I>Committee</I></B>&rdquo;) appointed by the
Board of Directors, and if the Committee is so appointed all references to the Board of Directors in the Plan shall mean and relate
to such Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Applicability
of Rule 16b-3</U></I>. Those provisions of the Plan which make express reference to Rule 16b-3 promulgated under the Securities
Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;), or any successor rule (&ldquo;<B><I>Rule 16b-3</I></B>&rdquo;),
or which are required in order for certain stock or option transactions to qualify for exemption under Rule 16b-3, shall apply
only to such persons as are required to file reports under Section 16(a) of the Exchange Act (a &ldquo;<B><I>Reporting Person</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>General</U></I>.
Stock Awards may be granted only to persons who are, at the time of grant, employees, officers or directors of, or consultants
or advisors to, the Company (collectively, the &ldquo;<B><I>Participants</I></B>&rdquo;); <U>provided</U>, that the class of Participants
to whom Incentive Stock Options may be granted shall be limited to employees of the Company. A person who has been granted a Stock
Award may, if he or she is otherwise eligible, be granted additional Stock Awards if the Board of Directors shall so determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Grant
of Stock Awards to Directors and Officers After Exchange Act Registration</U></I>. From and after the registration of the Common
Stock of the Company under the Exchange Act, in the discretion of the Board, the selection of a director or an officer (as the
terms &ldquo;director&rdquo; and &ldquo;officer&rdquo; are defined for purposes of Rule 16b-3) as a recipient of a Stock Award,
the timing of the Stock Award grant, the purchase or exercise price of the Stock Award, the number of shares subject to the Stock
Award and other terms and conditions shall be determined either (i) by the Board of Directors, of which all members shall be &ldquo;outside
directors&rdquo; and/or &ldquo;non-employee directors&rdquo; (as hereinafter defined) or (ii) by the Committee referenced in Section
2(b)(ii) above, consisting of two or more directors having full authority to act in the matter, each of whom shall be an &ldquo;outside
director&rdquo; and/or &ldquo;non-employee director&rdquo; (with any action of the Committee subject to approval or ratification
by the Board, if required). For the purposes of the Plan, a director shall be deemed to be a &ldquo;non-employee director&rdquo;
only if such person qualifies as a &ldquo;non-employee director&rdquo; within the meaning of Rule 16b-3, as such term is interpreted
from time to time, and shall be deemed to be an &ldquo;outside director&rdquo; only if such director qualifies as an &ldquo;outside
director&rdquo; within the meaning of Section 162(m) of the Code and the applicable Treasury regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Subject to Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Initial
Share Reserve</U></I>. Subject to adjustment as provided in Section 11 below, the number of shares of Common Stock which are
initially set aside and reserved for issuance under the Plan is 2,565,724 shares, (which includes a total of 565,724 shares
of Common Stock that were previously held in reserve under the 1995 Stock Option Plan, but which were unused, and which have
been transferred to this Plan). Additionally, if any outstanding stock option granted under the Company&rsquo;s 1995 Stock
Option Plan should for any reason expire or otherwise terminate, in whole or in part, without having been exercised in full,
the shares of common stock that are not acquired under any such stock option shall revert to, and become available for
issuance under, this 2005 Stock Incentive Plan. The maximum aggregate number of shares of Common Stock that may be delivered
in satisfaction of Stock Awards under the 2005 Stock Incentive Plan  is 26,312,192 shares. Subject
to adjustment as provided in Section 11 below, no employee shall be eligible to be granted stock options or stock
appreciation rights covering more than 900,000 shares of Common Stock during any calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Reversion
of Shares to the Share Reserve</U></I>. If any Stock Award under this Plan shall for any reason expire or otherwise terminate,
in whole or in part, without having been exercised in full, or if any shares of Common Stock issued to a Participant pursuant to
a Stock Award are forfeited back to or repurchased by the Company, including, but not limited to, any repurchase or forfeiture
caused by the failure to meet a contingency or condition required for the vesting of such shares, then the shares of Common Stock
not acquired or returned under such Stock Award shall revert to and again become available for issuance under the Plan. If any
shares subject to a Stock Award are not delivered to a Participant because such shares are withheld for the payment of taxes or
the Stock Award is exercised through a reduction of shares subject to the Stock Award (<I>i.e.</I>, &ldquo;net exercised&rdquo;),
then the number of shares that are not delivered shall revert to and again become available for issuance under the Plan. If the
exercise price of any Stock Award is satisfied by tendering shares of Common Stock held by the Participant (either by actual deliver
or attestation), then the number of such tendered shares shall revert to and again become available for issuance under the Plan.
Notwithstanding the above, and subject to Section 11 below related to capitalization adjustments, the maximum aggregate number
of shares that may be issued upon the exercise of Incentive Stock Options shall in no event exceed 26,312,192 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Option Provisions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Form
of Option Agreements</U></I>. As a condition to the grant of an option under the Plan, each recipient of an option shall execute
an option agreement in such form not inconsistent with the Plan as may be approved by the Board of Directors. Such option agreements
may differ among recipients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Purchase
Price</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>General</U></I>.
Subject to Section 3(b), the purchase price per share of stock deliverable upon the exercise of an option shall be determined by
the Board of Directors; <U>provided</U>, <U>however</U>, that the exercise price of an option shall not be less than 100% of the
&ldquo;Fair Market Value&rdquo; (as defined below) of such stock, as determined by the Board of Directors, at the time of grant
of such option, or less than 110% of such Fair Market Value in the case of options described in Section&nbsp;6. For purposes of
this Plan, the term &ldquo;Fair Market Value&rdquo; means, as of any date, the value of the Common Stock determined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Common Stock is listed on any established stock exchange or traded on the Nasdaq National Market or the Nasdaq SmallCap Market,
the Fair Market Value of a share of Common Stock shall be the closing sales price for such stock (or the closing bid, if no sales
were reported) as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common
Stock) on the day of determination, as reported in <I>The Wall Street Journal</I> or such other source as the Board deems reliable.
If the day of determination is not a market trading day, then the trading day prior to the day of determination shall be used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the absence of such markets for the Common Stock, the Fair Market Value shall be determined in good faith by the Board and consistent
with the requirements of Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Payment
of Purchase Price</U></I>. Options granted under the Plan may provide for the payment of the exercise price by delivery of cash
or a check to the order of the Company in an amount equal to the exercise price of such options, or, to the extent provided in
the applicable option agreement, (i) by delivery to the Company of shares of Common Stock of the Company already owned by the optionee
having a Fair Market Value equal in amount to the exercise price of the options being exercised, or (ii) by any other means approved
by the Board, as may be recommended by the Committee referenced in Section 2(b)(ii) above. The Fair Market Value of any shares
of the Company&rsquo;s Common Stock or other non-cash consideration which maybe delivered upon exercise of an option shall be determined
by the Board of Directors. If the exercise price of an option is being paid by delivery of already-owned Common Stock of the Company
that has been acquired from the Company, directly or indirectly, the Company may require that such already-owned shares have been
held by the optionee for a period of more than six (6) months (or such longer or shorter period of time to avoid a charge to earnings
for financial accounting purposes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Option
Period</U></I>. Each option and all rights thereunder shall expire on such date as shall be set forth in the applicable option
agreement, except that, in the case of an Incentive Stock Option, such date shall not be later than ten years after the date on
which the option is granted and, in all cases, options shall be subject to earlier termination as provided in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Exercise
of Options</U></I>. Each option granted under the Plan shall be exercisable either in full or in installments at such time or times
during such period and subject to such conditions as shall be set forth in the agreement evidencing such option, subject to the
provisions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Nontransferability
of Options</U></I>. Options shall not be assignable or transferable by the person to whom they are granted, either voluntarily
or by operation of law, except by will or the laws of descent and distribution, and, during the life of the optionee, shall be
exercisable only by the optionee; <U>provided</U>, <U>however</U>, that Non-Statutory Options maybe transferred pursuant to a qualified
domestic relations order (as defined in Rule 16b-3) or as otherwise expressly permitted in the agreement evidencing any such Non-Statutory
Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Effect
of Termination of Employment or Other Relationship</U></I>. Except as provided in Section&nbsp;6 with respect to Incentive Stock
Options, and subject to the provisions of the Plan, the Board of Directors shall determine the period of time during which an optionee
may exercise an option following (i)&nbsp;the termination of the optionee&rsquo;s employment or other relationship with the Company
or (ii)&nbsp;the death or disability of the optionee. Such periods shall be set forth in the agreement evidencing such option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Special Provisions for Incentive
Stock Options</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Options granted under the Plan which are
intended to be Incentive Stock Options shall be subject to the following additional terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Express
Designation</U></I>. All Incentive Stock Options granted under the Plan shall, at the time of grant, be specifically designated
as such in the option agreement covering such Incentive Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>10%
Stockholder</U></I>. If any employee to whom an Incentive Stock Option is to be granted under the Plan is, at the time of the grant
of such option, the owner of stock possessing more than 10% of the total combined voting power of all classes of stock of the Company
(after taking into account the attribution of stock ownership rules of Section 424(d) of the Code), then the following special
provisions shall be applicable to the Incentive Stock Option granted to such Individual:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
purchase price per share of the Common Stock subject to such Incentive Stock Option shall not be less than 110% of the Fair Market
Value of one share of Common Stock at the time of grant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
option exercise period shall not exceed five years from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Dollar
Limitation</U></I>. For so long as the Code shall so provide, options granted to any employee under the Plan (and any other incentive
stock option plans of the Company) which are intended to constitute Incentive Stock Options shall not constitute Incentive Stock
Options to the extent that such options, in the aggregate, become exercisable for the first time in any one calendar year for shares
of Common Stock with an aggregate Fair Market Value (determined as of the respective date or dates of grant) of more than $100,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Termination
of Employment, Death or Disability</U></I>. No Incentive Stock Option may be exercised unless, at the time of such exercise, the
optionee is, and has been continuously since the date of grant of his or her option, employed by the Company, except that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
Incentive Stock Option may be exercised within the period of three months after the date the optionee ceases to be an employee
of the Company (or within such lesser period as may be specified in the applicable option agreement), <U>provided</U>, that the
agreement with respect to such option may designate a longer exercise period and that the exercise after such three-month period
shall be treated as the exercise of a Non-Statutory Option under the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the optionee dies while in the employ of the Company, or within three months after the optionee ceases to be such an employee,
the Incentive Stock Option may be exercised by the person to whom it is transferred by will or the laws of descent and distribution
within the period of one year after the date of death (or within such lesser period as may be specified in the applicable option
agreement); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the optionee becomes disabled (within the meaning of Section 22(e)(3) of the Code or any successor provision thereto) while in
the employ of the Company, the Incentive Stock Option may be exercised within the period of one year after the date the optionee
ceases to be such an employee because of such disability (or within such lesser period as maybe specified in the applicable option
agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
all purposes of the Plan and any option granted hereunder, &ldquo;employment&rdquo; shall be defined in accordance with the provisions
of Section 1.421-7(h) of the Income Tax Regulations (or any successor regulations). Notwithstanding the foregoing provisions, no
Incentive Stock Option may be exercised after its expiration date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Provisions Related to Stock Options</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Additional
Option Provisions</U></I>. The Board of Directors may, in its sole discretion, include additional provisions in option agreements
covering options granted under the Plan, including without limitation restrictions on transfer, repurchase rights, or such other
provisions as shall be determined by the Board of Directors; <U>provided</U> <U>that</U> such additional provisions shall not be
inconsistent with any other term or condition of the Plan and such additional provisions shall not cause any Incentive Stock Option
granted under the Plan to fail to qualify as an Incentive Stock Option within the meaning of Section 422 of the Code, and shall
not cause any option to violate the requirements of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Acceleration
or Extension of Exercise Dates</U></I>. The Board of Directors may, in its sole discretion, (i)&nbsp;accelerate the date or dates
on which all or any particular option or options granted under the Plan may be exercised or (ii)&nbsp;extend the dates during which
all, or any particular, option or options granted under the Plan may be exercised, but in no event beyond the original term of
the option grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
of Stock Awards Other Than Options</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Restricted
Stock Awards</U></I>. As a condition to the grant of an award of restricted stock under the Plan, each recipient of a restricted
stock award shall execute a restricted stock award agreement in such form not inconsistent with the Plan as may be approved by
the Board of Directors. The terms and conditions of restricted stock award agreements may change from time to time, and the terms
and conditions of separate restricted stock award agreements need not be identical; <I>provided</I>, <I>however</I>, that each
restricted stock award agreement shall include (through incorporation of the provisions hereof by reference in the agreement or
otherwise) the substance of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Purchase
Price</U></I>. At the time of the grant of a restricted stock award, the Board will determine the price to be paid by the Participant
for each share subject to the restricted stock award. To the extent required by applicable law, the price to be paid by the Participant
for each share of restricted stock will not be less than the par value of a share of Common Stock. A restricted stock award may
be awarded as a stock bonus (<I>i.e.</I>, with no cash purchase price to be paid) to the extent permissible under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Consideration</U></I>.
At the time of the grant of a restricted stock award, the Board will determine the consideration permissible for the payment of
the purchase price of the restricted stock. The purchase price of Common Stock acquired pursuant to the award shall be paid in
one of the following ways: (i) in cash at the time of purchase; (ii) by services rendered or to be rendered to the Company; or
(iii) in any other form of legal consideration that may be acceptable to the Board; <I>provided, however</I>, that at any time
that the Company is incorporated in Delaware, the Common Stock&rsquo;s &ldquo;par value,&rdquo; as defined in the Delaware General
Corporation Law, shall not be paid by deferred payment unless permissible under the Delaware Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Vesting</U></I>.
Shares of Common Stock acquired under a restricted stock award may, but need not, be subject to a share repurchase option in favor
of the Company in accordance with a vesting schedule to be determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Termination
of Participant&rsquo;s Service</U></I>. In the event that a Participant&rsquo;s service as an employee, director, consultant or
advisor to the Company terminates, the Company may repurchase or otherwise reacquire any or all of the shares of Common Stock held
by the Participant that have not vested as of the date of termination under the terms of the restricted stock award agreement.
The Company may delay the exercise of its repurchase option for such period of time required to avoid a charge to earnings for
financial accounting purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Transferability</U></I>.
Rights to purchase or receive shares of Common Stock granted under a restricted stock award shall be transferable by the Participant
only upon such terms and conditions as are set forth in the restricted stock award agreement, as the Board shall determine in its
discretion, and so long as Common Stock awarded then remains subject to the terms of the restricted stock award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Restricted
Stock Units</U></I>. As a condition to the grant of a unit of restricted stock under the Plan, each recipient of a restricted stock
unit shall execute a restricted stock unit agreement in such form not inconsistent with the Plan as may be approved by the Board
of Directors. The terms and conditions of restricted stock unit agreements may change from time to time, and the terms and conditions
of separate restricted stock unit agreements need not be identical; <I>provided</I>, <I>however</I>, that each restricted stock
unit agreement shall include (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance
of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Consideration</U></I>.
At the time of grant of a restricted stock unit award, the Board will determine the consideration, if any, to be paid by the Participant
upon delivery of each share of Common Stock subject to the restricted stock unit award. To the extent required by applicable law,
the consideration to be paid by the Participant for each share of Common Stock subject to a restricted stock unit award will not
be less than the par value of a share of Common Stock. Such consideration may be paid in any form permitted under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Vesting</U></I>.
At the time of the grant of a restricted stock unit award, the Board may impose such restrictions or conditions to the vesting
of the shares restricted stock unit as it deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Payment</U></I>.
A restricted stock unit award may be settled by the delivery of shares of Common Stock, their cash equivalent, or an combination
of the two, as the Board deems appropriate. Settlement of such restricted stock unit award shall occur no later than two and one-half
(2&frac12;) months following the year in which such restricted stock unit award vests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Additional
Restrictions</U></I>. At the time of the grant of a restricted stock unit award, the Board, as it deems appropriate, may impose
such restrictions or conditions that delay the delivery of the shares of restricted stock (or their cash equivalent) after the
vesting of such Award; <U>provided</U> <U>that</U> no such restriction or condition shall cause a restricted stock unit award to
violate the requirements of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Dividend
Equivalents</U></I>. Dividend equivalents may be credited in respect of restricted stock units, as the Board deems appropriate.
Such dividend equivalents may be converted into additional restricted stock units by dividing (1) the aggregate amount or value
of the dividends paid with respect to that number of shares of Common Stock equal to the number of restricted stock units then
credited by (2) the Fair Market Value per share of Common Stock on the payment date for such dividend. The additional restricted
stock units credited by reason of such dividend equivalents will be subject to all the terms and conditions of the underlying award
to which they relate. Dividend equivalents shall be settled at the same time as the restricted stock unit awards to which they
relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Termination
of Participant&rsquo;s Service</U></I>. Except as otherwise provided in the applicable Stock Award agreement, restricted stock
units (and any related dividend equivalents) that have not vested will be forfeited upon the Participant&rsquo;s termination of
Continuous Service for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Stock
Appreciation Rights</U></I>. As a condition to the grant of a stock appreciation right under the Plan, each recipient of a stock
appreciation right shall execute a stock appreciation right agreement in such form not inconsistent with the Plan as may be approved
by the Board of Directors. The terms and conditions of stock appreciation right agreements may change from time to time, and the
terms and conditions of separate agreements need not be identical, but each agreement shall include (through incorporation of the
provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Calculation
of Appreciation</U></I>. Each stock appreciation right will be denominated in shares of Common Stock equivalents. The appreciation
distribution payable on the exercise of a stock appreciation right will be not greater than an amount equal to the excess of (A)
the aggregate Fair Market Value (on the date of the exercise of the stock appreciation right) of a number of shares of Common Stock
equal to the number of shares of Common Stock equivalents in which the Participant is vested under such stock appreciation right
and with respect to which the Participant is exercising the stock appreciation right on such date, over (B)&nbsp;the aggregate
Fair Market Value (on the date of grant of the stock appreciation right), or such higher value assigned by the Committee, of the
same number of Common Stock equivalents awarded to the Participant under the stock appreciation right award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Vesting</U></I>.
At the time of the grant of a stock appreciation right, the Board may impose such restrictions or conditions to the vesting of
such right as it deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Exercise</U></I>.
To exercise any outstanding stock appreciation right, the Participant must provide written notice of exercise to the Company in
compliance with the provisions of the stock appreciation rights agreement evidencing such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Payment</U></I>.
The appreciation distribution in respect of a stock appreciation right may be paid in Common Stock, in cash, or any combination
of the two, as the Board deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Termination
of Participant&rsquo;s Service</U></I>. If a Participant&rsquo;s service as an employee, director, consultant or advisor to the
Company terminates for any reason, any unvested stock appreciation rights shall be forfeited and any vested stock appreciation
rights shall be automatically redeemed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Investment
Representations</U></I>. The Company may require any person to whom a Stock Award is granted, as a condition of receiving or exercising
such Stock Award, as applicable, to give written assurances in substance and form satisfactory to the Company to the effect that
such person is acquiring the Common Stock subject to the Stock Award for his or her own account for investment and not with any
present intention of selling or otherwise distributing the same, and to such other effects as the Company deems necessary or appropriate
in order to comply with federal and applicable state securities laws, or with covenants or representations made by the Company
in connection with any public offering of its Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Compliance
With Securities Laws</U></I>. Each Stock Award shall be subject to the requirement that if, at any time, counsel to the Company
shall determine that the listing, registration or qualification of the shares subject to such Stock Award upon any securities exchange
or under any state or federal law, or the consent or approval of any governmental or regulatory body, or that the disclosure of
non-public information or the satisfaction of any other condition is necessary as a condition of, or in connection with, the issuance
or purchase of shares thereunder, such Stock Award may not be issued or exercised, as applicable in whole or in part, unless such
listing, registration, qualification, consent or approval, or satisfaction of such condition shall have been effected or obtained
on conditions acceptable to the Board of Directors. Nothing herein shall be deemed to require the Company to apply for or to obtain
such listing, registration or qualification, or to satisfy such condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
as a Stockholder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The holder of an option shall have no rights
as a stockholder with respect to any shares covered by the option (including, without limitation, any rights to receive dividends
or non-cash distributions with respect to such shares) until the date of issue of a stock certificate to him or her for such shares.
No adjustment shall be made for dividends or other rights for which the record date is prior to the date such stock certificate
is issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
Provisions for Recapitalizations and Related Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
(i) the outstanding shares of Common Stock are (A) exchanged for a different number or kind of shares or other securities of the
Company or (B) increased or decreased as a result of any recapitalization, reclassification, stock dividend, stock split or reverse
stock split or (ii) additional shares or new or different shares or other securities of the Company or other non-cash assets are
distributed with respect to such shares of Common Stock or other securities, an appropriate and proportionate adjustment shall
be made in (x) the maximum number and kind of shares reserved for issuance under the Plan, (y) the number and kind of shares or
other securities subject to any then outstanding Stock Awards under the Plan, and (z) the price for each share subject to any then
outstanding Stock Awards under the Plan, without changing the aggregate purchase price for such Stock Awards or as to which such
options remain exercisable. Notwithstanding the foregoing, no adjustment shall be made pursuant to this Section 11 if such adjustment
would cause the Plan to fail to comply with Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
adjustments under this Section 11 will be made by the Board of Directors, whose determination as to what adjustments, if any, will
be made and the extent thereof will be final, binding and conclusive. No fractional shares will be issued under the Plan on account
of any such adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Merger,
Consolidation, Asset Sale, Liquidation, etc</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>General</U></I>.
In the event of (i) a consolidation, merger, combination or reorganization of the Company, in which outstanding shares of Common
Stock are exchanged for securities, cash or other property of any other corporation or business entity, (ii) the sale, lease or
other disposition of all or substantially all of the assets of the Company, (iii) a transaction or series of related transactions
involving a person or entity, or a group of affiliated persons or entities (but excluding any employee benefit plan or related
trust sponsored or maintained by the Company or an affiliate) in which such persons or entities that were not shareholders of the
Company immediately prior to their acquisition of Company securities as part of such transaction become the owners, directly or
indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company&rsquo;s
then outstanding securities (a &ldquo;<B><I>Securities Acquisition</I></B>&rdquo;) other than by virtue of a merger, consolidation
or similar transaction, or (iv) a dissolution or liquidation of the Company (hereinafter, each of the events described in (i) through
(iv) above shall be a &ldquo;<B><I>Corporate Transaction</I></B>&rdquo;), then the Board of Directors of the Company, shall take
any one or more of the following actions, as to outstanding Stock Awards: (i) provide that such Stock Awards shall continue in
existence with appropriate adjustments or modifications, if applicable, or provide that such Stock Awards shall be assumed, or
equivalent stock awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), <U>provided</U>
that any such options substituted for Incentive Stock Options shall meet the requirements of Section 424(a) of the Code, (ii) upon
written notice to the Participants, provide that all unexercised options, or other Stock Awards to the extent they are unexercised
or unvested (<U>i.e.</U>, in the case of restricted stock, the Company has a reacquisition or repurchase right as to the stock),
including Stock Awards that are &ldquo;out-of-the-money&rdquo; or &ldquo;underwater,&rdquo; will terminate immediately prior to
the consummation of such transaction unless exercised by the Participant within a specified period following the date of such notice,
if applicable, (iii) in the event of a consolidation, merger, combination, reorganization or Securities Acquisition under the terms
of which holders of the Common Stock of the Company will receive upon consummation thereof a cash payment for each share surrendered
in the transaction (the &ldquo;<B><I>Sale Price</I></B>&rdquo;), make or provide for a cash payment to the Participant equal to
the difference between (A) the Sale Price times the number of shares of Common Stock subject to such outstanding Stock Awards (to
the extent then vested or exercisable at prices not in excess of the Sale Price), and (B) the aggregate exercise price of all such
outstanding Stock Awards in exchange for the termination of such Stock Awards, or (iv) provide that all or any outstanding Stock
Awards shall become vested and exercisable in full or part (or any reacquisition or repurchase rights held by the Company shall
immediately lapse in full or part) at or immediately prior to such event. To the extent set forth in any option agreement or other
stock award agreement, the Board or its designee may specifically provide, either at the time of grant or thereafter, that any
of the preceding actions shall or shall not occur or be taken with respect to an outstanding award.</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Change
in the Incumbent Board</U></I>. The Board or its designee may provide for the accelerated vesting or exercisability of a Stock
Award (including the lapse of any reacquisition or repurchase rights in favor of the Company) upon the occurrence of a Change in
the Incumbent Board (as defined below) in any option agreement or other stock award agreement at the time of grant of the Stock
Award, or at any time thereafter. A &ldquo;<B><I>Change in the Incumbent Board</I></B>&rdquo; shall be deemed to occur if the existing
members of the Board on the date this Plan is initially adopted by the Board (the &ldquo;<B><I>Incumbent Board</I></B>&rdquo;)
cease to constitute at least a majority of the members of the Board, <U>provided</U>, <U>however</U>, that any new Board member
shall be considered a member of the Incumbent Board for this purpose if the appointment or election (or nomination for such election)
of the new Board member was approved or recommended by a majority vote of the members of the Incumbent Board who are then still
in office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Substitute
Options</U></I>. The Company may grant Stock Awards under the Plan in substitution for Stock Awards held by employees of another
corporation who become employees of the Company, or a subsidiary of the Company, as the result of a merger, consolidation, combination
or reorganization of the employing corporation with the Company or a subsidiary of the Company, or as the result of the acquisition
by the Company, or one of its subsidiaries, of property or stock of the employing corporation. The Company may direct that substitute
Stock Awards be granted on such terms and conditions as the Board of Directors considers appropriate in the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Special Employment Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Nothing contained in the Plan or in any
Stock Award shall confer upon any Participant any right with respect to the continuation of his or her employment by the Company
or interfere in any way with the right of the Company at any time to terminate such employment or to increase or decrease the compensation
of the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Employee Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as to plans which by their terms
include such amounts as compensation, the amount of any compensation deemed to be received by an employee as a result of the issuance
of a Stock Award, the lapse of any restrictions thereon, or the exercise of an option, or the sale of shares received upon such
exercise will not constitute compensation with respect to which any other employee benefits of such employee are determined, including,
without limitation, benefits under any bonus, pension, profit-sharing, life insurance or salary continuation plan, except as otherwise
specifically determined by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment
of the Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors may at any time, and from time to time, modify or amend the Plan in any respect, except that if at any time
the approval of the stockholders of the Company is required under Section 422 of the Code or any successor provision with respect
to Incentive Stock Options, or under Rule 16b-3 (if then applicable), the Board of Directors may not effect such modification or
amendment without such approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
modification or amendment of the Plan shall not, without the consent of a Participant, adversely affect the Participants rights
under a Stock Award previously granted to him or her. With the consent of the affected Participant, the Board of Directors may
amend outstanding Stock Award agreements in a manner not inconsistent with the Plan. The Board of Directors shall have the right
to amend or modify (i) the terms and provisions of the Plan and of any outstanding Incentive Stock Options granted under the Plan
to the extent necessary to qualify any or all such options for such favorable federal income tax treatment (including deferral
of taxation upon exercise) as may be afforded incentive stock options under Section 422 of the Code and (ii) the terms and provisions
of the Plan and of any outstanding Stock Award to the extent necessary to ensure the qualification of the Plan under Rule 16b-3
(if then applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have the right to deduct from payments of any kind otherwise due to a Participant any federal, state or local taxes
of any kind required by law to be withheld with respect to any shares issued pursuant to a Stock Award or upon exercise of options
under the Plan, and including the lapse of any restrictions with respect to a Stock Award. Subject to the prior approval of the
Company, which may be withheld by the Company in its sole discretion, a Participant may elect to satisfy such obligations, in whole
or in part, (i) by causing the Company to withhold shares of Common Stock otherwise issuable pursuant to the exercise of an option
or (ii) by delivering to the Company shares of Common Stock already owned by the Participant. The shares so delivered or withheld
shall have a Fair Market Value equal to such withholding obligation. The Fair Market Value of the shares used to satisfy such withholding
obligation shall be determined by the Company as of the date that the amount of tax to be withheld is to be determined. A Participant
who has made an election pursuant to this Section 16(a) may only satisfy his or her withholding obligation with shares of Common
Stock which are not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, in the case of a Reporting Person, no election to use shares for the payment of withholding taxes shall be effective
unless made in compliance with any applicable requirements of Rule 16b-3 (unless it is intended that the transaction not qualify
for exemption under Rule 16b-3).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective
Date and Duration of the Plan</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Effective
Date</U></I>. The Plan shall become effective when adopted by the Board of Directors, but no Stock Award granted under the Plan
shall become exercisable, and no restricted stock award shall be granted, unless and until the Plan shall have been approved by
the Company&rsquo;s stockholders. If such stockholder approval is not obtained within twelve months after the date of the Board&rsquo;s
adoption of the Plan, options previously granted under the Plan shall not vest and shall terminate and no options shall be granted
thereafter. Amendments to the Plan not requiring stockholder approval shall become effective when adopted by the Board of Directors;
amendments requiring stockholder approval (as provided in Section&nbsp;15) shall become effective when adopted by the Board of
Directors, but no option granted after the date of such amendment shall become exercisable (to the extent that such amendment to
the Plan was required to enable the Company to grant such option to a particular person) unless and until such amendment shall
have been approved by the Company&rsquo;s stockholders. If such stockholder approval is not obtained within twelve months of the
Board&rsquo;s adoption of such amendment, any options granted on or after the date of such amendment shall terminate to the extent
that such amendment was required to enable the Company to grant such option to a particular optionee. Subject to this limitation,
Stock Awards may be granted under the Plan at any time after the effective date and before the date fixed for termination of the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Termination</U></I>.
The Board may suspend or terminate the Plan at any time. Suspension or termination of the Plan shall not adversely affect a Participant&rsquo;s
rights under a Stock Award previously granted to the Participant while the Plan is in effect except with the consent of the Participant.
Unless sooner terminated in accordance with this Section or Section&nbsp;12, the Plan shall terminate upon the close of business
on the day next preceding the tenth anniversary of the date of its adoption by the Board of Directors. Stock Awards outstanding
on such date shall continue to have force and effect in accordance with the provisions of the instruments evidencing such Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provision
for Foreign Participants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors may, without amending
the Plan, modify Stock Awards or options granted to Participants who are foreign nationals or employed outside the United States
to recognize differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities,
currency, employee benefit or other matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>v386486_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><B>Exhibit 23.2&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have issued our reports
dated March 12, 2014 with respect to the financial statements, schedule and internal control over financial reporting
included in the Annual Report of Novavax, Inc. on Form 10-K for the year ended December&nbsp;31, 2013. We hereby consent to
the incorporation by reference of said reports in this Registration Statement of Novavax, Inc. on Form S-8.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/Grant Thornton LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">McLean, Virginia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 13, 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tex5-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex5-1logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`4P#,`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`.%_+J^`74/RJ^"GR4^2&]-W]W;>^0.R.XOD[#L;L_9/=
M'8.WJW;$G7IGR^TC382FS/\``*B#'UATNKTY,T3,NH`W$F;SS%=P[W960`,3
M*@/YX/\`+J%.6.6[*]Y9N+YB?&5IJ9]&8_ZN'5W7\MKY)]K]J?RB.J_DAO\`
MSIW9VU1]"]C9W([CR<48GW%G.O#NZ@PV6R\,06GEKJNGV]3FK(&F64,W]H^P
MAO%E';<RK8Q@"&:1<#RU4QT/N7=RGN>4%G3_`'(BA=03_1U4ZH_Z^^$^QNX/
MY1^Y?YKV^>P>YJ[^8!7=8=D_(S#_`"+I>S-R4.X]J;AV;N#<;X+:FWL)2UJ;
M<I]F0XW$BF%(].W[<AN0./8JN=TN(-]AY94+^[](4K3U'&OVF@'#CT"TY=M+
MC8;GF6X!.\4=@WR'''V5ZMR^4/;6]NS_`.07O_NS<&1:+L'>WP7V]O7-9K'N
MV/GEW+E-L8"LR.4A>B$)I9*NL9I2([!68@`#CV2[=;^!S;#:CBET/\->A-NL
MWUG(-Q,3\>VD?\985ZJ[^1/Q#V;\,/Y<7QN_F$_%OL+N[JWY&XRA^)>Z=RY.
M+N'?>X]H=@1=J9#9E%O7![FV?N?+9;#28O*5&;>81QQ)&A&G05/!W8[I/N^]
MW.QWH5K01R$8X%2Q4\<TIT%KG9K/9>5K/>MOU+>&6(UKQK2OET?C^=?M>B[.
MWU_*BZOW+69RGV=V]\R,=LO?M#MG<6;VK4Y;;>XMG+%DJ%<G@*RAR-.9`UT9
M)0T7X/M#R,US:'<9X2*1VA'_`!X_ZAT?\[-!>WNSVUY4K+.<^GP?Y^K'NAO@
M]\>O@=MOM[='Q\P.[\56[FVP<GG8]W]E[\["IZJ79F-S-?AQ3P[US^9&-TRU
M<@E-.4\JFS?0>PQ>;SN&[?2VEQ0PK)Y#A4BO[:="2PV#;=B@G>S!UL&85-<@
M5'EUK(=,_%;9?RA_E8?(W^:UVYO3MG,?.W&_Z?\`M#97>%#V+N?#Y'K?(=1Y
MK+?W/V_LW"8W(Q82CVM24^+$;TLD,BF-]`X5?8]O]SFVW?+?EVV`^@:/*T]>
M.?S'\_RC+9MH3=>5Y>9[ZO[[19M#5P`.&/\`5Y=;;_Q%WSN/L[XK?&_L7>-<
M,GNS?/1O5FZ]S9(1I%_$,]GME87)9:N,<:K'&U975#R$*`H+<`#CW'>XPQP7
MTL,7]FKD#[.I<V>YEN]K@N9_[5XP3]O1B/:/HRZ"KN;NWJ_X^;$JNR^W]TQ[
M0V729K;&W'RIQ6=SM14;@WKN+&;2VGA,;A-LXO,Y[+9;<&Y<S2T5+3TM+-++
M/.H"_GW[KW0)TGSZ^(=;UUN'M*/NK"0[6VKOC$=99VDK\%O'%[ZH^Q]Q4%'E
MMN;"3JO);<I.T*W>6Y,/D(JW&XRGP\M;D*)C44\<D*LZ^Z]U"R?\PGX>8K9F
MR=^R]S45?@>Q-T;KV1M2FV_L_L/=&[*O>6Q*22OWOM/);`VWM'+;\VWN39]%
M&9<I19/&T=30(5,Z)J6_NO=0,K_,<^&.+_NEX>YH]S?WXV!BNT=MCKW8/:/9
MQJMAYK<&Y=J8W<%<.NMD[H."BJ-T;,R^.,%?]K51UV,JH'C66"15]U[I<R_-
M7XNT_;M'T54=NX6F[,KMPXK9D&(J,5N>GPB;\SN`@W3A>N*S?,V#38>.[-RV
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MJ?C52T:FN.6D[WH\A6T%7UB<)]G_`!B/<U,F.GK71H!&N(B;)%_X?_E/OW7N
MA#Q78>RLYOC>/6V)W%05V^NO\1M#/;SVU"9OXAM[#[^.XALZOK@\2PB#/G:6
M2\&AV/\`DCZ@O%_=>Z"7=/RW^.VS>D]H_(O/=FXV/IG?\NSJ?8^],7B-R[BC
MW=5=@U4%%LJCV[@]NX7*[FR]=N2KJHTI8(*)YG+?I%C;W7NEGTSWKU/\A-I5
M.]^GMYT&\]NX_/Y3:F7E@I,KB,IM_=.$^W;+;:W/MO<%!B=R;8W!0PUD$LE%
MD*2FJ1!40RZ/%+&[>Z]T+7OW7NO>_=>Z][]U[K6N_DE$C^5A\N+6Y[N^9O'^
M`QTM[?T)'L;;_P")_6.QP--(J^O$4ZBGDU&CY.OQ":D-.!7_`&U:_MZ%O^4N
M/^Q"77S<W_V7+Y"#@\>G(=F>TN\*C\Y6XS3QX_YE0>C78XW@Y)N#4AQ;S4_)
M6(/[>@&^-K%O^$OU=>UA\*>\A8?X93?(!_VWM;N#E^?45J4^HA'Y$J#TFVJ5
M_P#6TDF.9&MI:D_/6#_+H6^VN?\`A-?7G_P7=M#_`'C9^W_>D'_,0E_Y[`OY
M5`Z>D'A>VS*,CZ!N/S'^ST''\R0@?R`.CAQQL3X#GC\WW!UA;_>O?MC5WYLN
MHHQ^KHG_`.?ATGYF>)>1;1SB+Q(>'Y=#7_-L_P"9\?R5N21_L^6T3S_X:4?M
MOEI?\0W4L2)EMJ8X?CK7ISF[_<O90H)4W-:TJ0*1^?E7^?5YFZ<0=P;9W'MX
MR^#^/83+X19K7\7\4Q]30^7Z<F,3ZO\`8>P=:^%;O'J)T*P)]:5J?]CJ0;M6
MGMY(H1^J8V`KPJ10=:Y_\F_KG:/;G\N#Y5?RVNS*[,;7WOU7VQ\A^@.ZL3C)
MJ6DW;A,-V)F<O58;=&+6LIZRGABRV+K9VHY)(9(G:"Y'-O8PYHGGL-X@WNW`
M:&1%,;,*C\Z4KQ]1Y=1SRC86UQRM<<KW#R+,A=9*$!P&.2I(_94=;!?3?66&
MZ6ZEZTZ@V[69'(8#J_8NU=@X6NS$D$N5K,7M/"T>#H*K)24L-/3/73TU$K2F
M.-$+DV4#CV$[FX>ZG>XD`$CFII@?D,]2'96L=C:1VD)8Q1J%!8U-!ZG&>A)]
ML=*NB;?.;H'=WR4Z=VAUMLW+Y';];2_(WXN]A9K/X+=$^S-S8/9G5O?W7W8.
M]LMM/<=+35=3C]U4.U]NU3X_0H:2J"(&75J'NO=$)VY\&?DAT/VA)VWLZ*'Y
M*[GZF^3&:[FVIN?M[N"OI^UOD3U;V9\?-Q]*2[*WMNG-8;+8/:/:OQGAS4N/
MVI5QT]+M_.;8E:&H%#D\AD\@?=>ZY?[(C\E>VOD%M7Y#;XS]=\;JO>_R`[4[
MAWW@^BNSL+7;TZOVU4?%#K/XX]>X&/=6<Z^R>V]Y;LWG/UTN1W/+28]*6D66
MFI::IJ5H15U'NO=,?8?P-[,Z=[\H,U\?.M>^-_=0P?&SKKKR*MZ\^=^Z/CSO
MG)=H8CO?Y,=Q=F;I[:JVK::N[1RN_,WW@N6_B-14.(LC5Y$+#&DP'OW7NEID
M/C)\NH?E6=\;!V+ANK-O[N^1'7W;V_=^[2^0&6K.DM[]98Q=E2;UP?<7Q$WI
MA=YX#*_)I\%M=\%0[QVDV#%374V*STN2IY:67'/[KW26^?\`\1_G#VM\HMO=
MY_'''[`RNY.N]L[$_P!`&Z=[;^QN`ZTZ[JL1E-QY3MS!=S=0UNR=SMW!N+<L
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MH]HMNV../(56"I$Q]UIKH?=>ZX':_P`D.LOG/W)V=M+HS&=F=/\`?>POB_LZ
MKWM3]M;8VCE>OZCJK+]R4^\*W);-SF,ER.?IZ?&]C4M73"CGUU/ADBLCZ2WN
MO=$SVE\5OF)OGX>_%7XA;VZQ/1%9\:.Q?B?EJ[NG9'>NR]P97/X3IS>%'+O7
M/]?4R;1KYMO9M,+1&KH8LI0S+,)3`X#@O[]U[JVCH/X^[0^/6`W9BMMYW?6\
M\]V'OBN[(['[#[-W/+NW?N_M[5N!V[M),WN'+?:X['Q#%[.V?B,/0TE#1T5#
M1XW&4\,4*Z26]U[H=??NO=>]^Z]U[W[KW6DK\#=F?S)<]_+<^6.2^*O;/1.W
M.F(>X_E%_>O8F:V7F3W=EJ:DE>7L*+8G8E7-D=G83+Y?`AH\2:S$SQ4\QLUB
M0PD[?391\R6<4X;ZA5B!_AJ:%?YD?ZAU"6Q1[Y+RY?1[7X7@>+)74:-QJU,4
MI3YBO5]7PDR7267_`),&R*[X[8;<^W^I'^)'8\.W,+O6MI,EO#'UM+MK=]-N
M>+<V2H(X:'(YA]TQ5CRSPHD4NH,BJI"@+7J31\Y1)/3Q!=IPX4U*1_+C\^AQ
M83PW/(;3P5T-82UKCN"N&_F#3Y=$0^-JE?\`A+]77_/PI[R/^WRN^?\`BGLQ
MOO\`E?T_YZ8/\*]$VUG_`)A>W_/+)_A;H7.V=(_X375Q>^G_`(;OVAJT_JM_
M=#;][7XO;W>/_IX(_P">X?X>EES_`-.X;_I7G_!T#NUOAG_,?^>'PT^)/1G<
M?8_Q-ZN^()V=\<M]9=^K<9V;G^\=X;(V-A=K;CVGMFL;<T%%L[#9&K2BIWK9
MH7=%G!TJRBQL=UVG:-VN+V`RMN+"5*4HH8D@FI\O\A/2&'9=[W;8+;;KH1"P
M5XWKJSI%#PIQXXQT*_\`/%Q._P"I[(_E+XCJ?-;<VUV0_P`W*"@Z_P`]O3&U
MFX-J8?<HVGX<)D-SXC'U%%DLMBJ>95:>&&:-Y%!&KGWODMH/H-UEO:U^D%:9
MSW]+>>'N(;W:4L91&#<$`%:U/93SP!U:Y\6-J_-;;5#O/_9RNT^B.S\C4U^-
M?8=1T?UWN?8-/B,;'1S)FH=P0[DS^=?)5556F-X&B,8CC#*0;^P5>):S46U#
M#A753_(3T*=M&]VQ=]WFBDB%2H12,#[?\'547S9II?Y<G\QCI;^8O@(9:#X[
M_**;!?&7YJ4E(A7%X7<%=.J=4=QY")%T1RT-5`E+43-_8IRMPTW(NVTMO^SG
M8F.K<H,P_,#)%?7R&/,=!'?V/*_,46^("-JN6"34R0S<#IXT\R?(UZV&X9HJ
MB&*>"1)H9XTFAFC8/'+%(H>.1'6ZLCHP((X(/L%$$&AP1U(X(8`C@>LGOW6^
M@4^0'?>ROC=UY_I)WW0;PR^+GW?L'8.)P6P=K9+>F\-P[Q[.WGA-@;*P&!VY
MBE:LKZW+[HW#2P#E4B5R[LJ*Q'NO=%>G_F6]%@X3#X[K_P"2F<[)RV]-X;`K
M^E,3T#OM^XMI[CV/LK9?8^<3=VRJVDHIL1BFV)V-@<K1Y`32T-=296$T\LC:
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M?=IY7M+IC=>QL=N3MNERW9.`W!M+$SY*-S-4;0SW4V;HLK,RI3TE33*I=O(A
M/NO=*NI^>?QHI\?\D\F-XY2HIOB=OO;O7?<OVVU-Q228O<.Z,AC,'C)-O*V/
M0;OPB[IK:G#3U^.-12T^8Q&3HW<3T%0B>Z]T9/L3>L?76R\]O27:^]-YQX&F
MAJ6VQUWMRIW;O3+^:LIJ,08';M&\=3E*F(U/D=$8%84=SPI]^Z]T1_:'\S?H
M3>W7.([(PVP_DBE)O/=K;%ZHVC7="[VI^P^ZMU4<&[:O<.-ZKV:M/-E-P4NR
MZ+8N4GSM?,*3&X>GI3+55$4;(S>Z]TO]K_S`/C9NB@RU:N?W7MNHVQUUW=V1
MO7![TV%NK:6Y-AT/QQJ=DP=T;9WG@,WC:7*8+?&R8.Q\'6MC)(S+7XO)T]?1
M&IHIHJA_=>Z0E?\`S0?BS#LGJC>V"G[2WQ'W5L3KW?\`L#:NR>J=WYW?-?CN
MT-YMU]L[!Y/:PHJ>OP&\*[=U'7T<N+K?!5TTF)K_`"J@I9;>Z]TI,Y\^]A[>
MCZ\H\AT5\M6WGV=%V3D-L=8TGQ\W76=D+MWJB?85'O#=N7VS!*SXC:\%?V9A
MZ>GJII5%5/4E(U)1[>Z]T9OI?N/8/?\`UEM?MSK+)5V4V9NV')''RY7"9G;.
M:H,A@LUDMM;DV_N#;>X:'&YW;VY-K[GPU9C<C0U=/%44E=22Q.H9#[]U[H4?
M?NO=>]^Z]UK8_P`DG_MU=\NO_$W?,_\`H?\`EVS?U!'N0N:O^5PMOMM_^?>H
MPY)_Y5S</^:LW_'.A<_E-,6_D(]>W_'QQ^0@')-@,AV98`DDV'X]E>\?\KQ%
M_P`]47_/G2OEW_IW'_4'<?X9>@"^-K%O^$OU=>W'PI[R''^&5WS_`,5]J+[_
M`)7]/^>F#_"O27:A_P`PO?\`YY9/\+="WVV+_P#":W(#^O\`+NVA_P"\?M_W
M>/\`Z>"/^>X?X>EES_T[=O\`I7G_``=6S?!G_LBSXC?^*T])?^^UVS["6Z_\
MEB;_`)K2?\>/0NV?_DBP_P#-)/\`CHZK0_G#?]E(?R;/_&@NW_\`WG3[$_*_
M_)+W7_GF'_/_`$#N=O\`DH[/_P`]?_6OJ\'<68AV[@LUN"ICEFI<'BLIF*J&
M`(9I:;%T4U=/%#Y&2/RR1P$+J(&HBY]@P*[LJ)\1<#^?4@3NL:^(_P`"J2?L
M`SU3)\J.Z.J_YBG\E+Y']WX3:N>Q&P]^]"=H;JV]A=X08V/<N&S76.3RDF)R
M$ZXNKR=%!4T>X]JB>)HIF)C(O;41[$^SV\^U\U015.K4`:>=1_L]`S<;NVYD
MY.GOU';(C.E<T\,D`UQYCT\^CQ?RX-X9[?WP&^'F\-SULF2S^>^.W557E:^8
MEIJRK7:6-IWJ)W))>>40@NQ)+,23R?9?O\4<&\W,40I&LIIT=\LS27&P6DTI
MK(T*UZ.K[*.CWHJ'S*^-\_RIZHVSU:F;;`X^B[Y^.?9VXJNGSV[-JY6IVKT]
MW;L;L[<V)V]NC8N0Q&[-M[ES.%VM-2X^NHJRDFIJN5'\T8!8>Z]T5_LO^59T
M9O/>_2`PE!G-O]7;(R?R!W7V=%!W'WO3=R[\[`[@V'L78>#WJW==+OYNT,EG
M-NXC9D5+YLCG)?#0T]'!`HCIH4C]U[I`]6_"+Y7_`!DGZFW+T5G?C+N_=G7/
M178?Q?R=#V%3;ZZ]VYN;8A[AK.R^I^Z<A)L#;&X*B;N.LAKJB7?^/^VCH]S9
MVNJ*^FR="69)/=>Z0^U?Y=?ROZAV1VGT)U+V!\?\AU9W;\6?CQ\9=U]J[\A[
M`3LK9M/U3TG7]);UWIMGJO#8:JV?N:OSN-RM1DL31UNYZ&"DJFCCJ340HPD]
MU[I2])_RZ^P.B_DUNGLS$]:?'3>FT,OWI2[_`-L]DY[NGO[`]P[0V$FQ]D["
M@PS==8O9.1ZLW+N;`8;:\O@EJ*^&"O:56F:)KL/=>ZP=`?RMM^="]K?`?L7;
MW:NU:;"=!]>KB?E%UY0X?)C;W;O;FU_C/NOXZ=>=W=>321PS;=WC%M?=;XG<
M35B6SN%QV),A2IQD9F]U[H:I?A-VKC.ING]J;=WAU]-O+J/YU]Z?,"BJ,S#N
M.+;66QW8N_\`Y-;ZVAM.I:BI)<I#78Z7NO%PY&54\9%%5&$F\5_=>Z*-F_Y/
MG:NU.L&P757R/R^]M\;ZZ&K.MN[$[ZW%F:[8NYM_TW;^W/DA@][;+I=K;9;*
M[6HF[NDW?-40U(R,T>/WI5%&:6GC23W7NKI.HJONNLVO/+WS@.K=N;T&7JTI
MJ#J+=V[-Z;7?`"GHS0U,^7WELG8.6CR\E6U0)8%HFA2-8RLK%F5/=>ZKXVI\
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MN[XVQVO61=:[XH<UA).N<S]U1U)GH8I*BBDB65E<1>Z]U8+\2.H=S=`_'3JS
MI3=LNP:S+]7X&?9J9?K3;?\`<_;&Y,/ALKD*;;VZYMK)#%38'=FZL"*;([@I
MZ8R4@SU36-3R/"R,?=>Z,;[]U[KWOW7NM;K^2GCJ^A_E;_+:"LH,A25,G=/S
M*>.EJZ"LHZJ1)L;,8WCIJJ&&9UE/"%5(8_0GV--]FBN.9;&[4X7POY$`_P"#
MJ,N4$O&Y4O99EI<R">@^S6!T.?\`)XVEGMQ_R0>G=CT=!40;CW+TGW7MG'4&
M4IY\9(,MG<_V#08V&JCK8Z::G2:IK8QJ8`:3>]N?:/>;A!S4EXA&B*9&)]*4
M_P`W1MRS:W$_)IMKA:2M#(FG[=7^?JIOK#YU=(]5_P`DG>'\O/>:=@XCYN8'
MJ?M/XW1?&]NM=\-V%G-_;IW!N#'X2NP$5)MV;&5>W*R+.Q5$=<L_B6-&Y)%R
M)+RVENN<$WB1E-B=+:JBF%H/SKP'GQZ#UO?00\H3;!`&%^R2(!3^*M?Y$_G3
MJU_Y0]:[OZP_X3Z;]ZLW;B:BEWSLSX'[?VSN+!TT4U95T>X<=M7`Q9+%"&!9
MYYZNDK`T3J@8EU-O9#M=S#+SG%.Q'@_5C/RZ-;W;Y[7VZDL%!-PMB4IYU/\`
MQ?5E7P=1XOA=\28IHY8)H_C9TI')!/%+!/%(G6^VEDCE@F2.:*2-@0RLH93P
M1?V%MVI]=(1P\5O^/'H8;*"-FA!XB%!^Q1U5%_/%WMMWK#M+^5%VAO2HK<;L
M7KCYN4>\=[9RCPV8S@P.VL1MCRY'*U%#@Z'(9&6&G0CB.)V8D``D^Q9R@"T5
MZ@(!>WTT)XDZJ=`?W"%J)=KFO/%\&.[#'0*\"AS^SJQ'IWYT?%;YOXSM;KSX
MU]IGL'=6$Z_R=5EZ*39F_MIICJ/<E/7X'$U356\=LX"GF6IR#A=,+R2*.6"C
MGV'7VN;;YH)9R`BR>1KQ-<_9T*XMYLMUCN8+'Q"_@GB*#@1C\SUKI]4_-GH/
MH3^3'VI_+^[3R>]-L?,K;FPOD!T0OQ]FZV[`FWSG][[RW5NV+;4VVQ1[<GQF
M8PV5CSL%1'6QU+1^/4Q-@+C==ON;KF^#=(6`M\-JKV@``&OSQ@?GY=`%=PM[
M;D>XVN96^I)9=(!KEJX_R_.GKULM_P`N_K[=O5'P4^)/7&_<3/@=Y[-Z!ZRP
M>YL)5$?=XG,TFU\>*W'58!;15TDS%)5O=)%(_'L';W/%<[O<3P?V+2DC[.I#
MY;MY;38;6VF73*D(!'IT<KV5='?0#_)+Y`;:^,W5.0[5W1@MP[FHX-Q;)V?C
M,#MJ3;M%793<_8F\,+L7:M)59[>6>VKLG:F&DW!GZ?[W+9K*8_&8^FURS3#2
M%;W7NBBT/\T7J7*X'8N[,1U+W?EMIY;:NW]\=M;EH,;UW48?X\[0W5W%NSH7
M`[D["K$[&,.[L)D.R-A9TQU>R3NFGEP&(J,U$\F.:FFJ?=>Z&7I/YK[)[O[1
MEZXQ77O9NTL=G</V?N3I[L?=]'M"'9'>FVNE^P<9U?V?G-A?P+>&=W1C(-O;
MLSE`T$.X,;AJG*8JO@KZ..:G,C1>Z]T#VV?YG75^4[&J]I[KZS[!Z]V)_I+^
M1O56*[ES^Y.F<MM2JW'\7(NU*WM#(YS9VTNT-P=O[)VC%B>F,_54F7R^W:2A
M=8*=)I():VC2;W7NG/"?S#OXA3[<K,U\3ODUL^#MG86\M^_&F'/XWJV;*_(8
M[+V55]D3;`VYA,%V=F<IU]VON?K_`!U3F,)@-WQX&>OHZ2I1GAJJ:HIHO=>Z
M<<;_`#*_C[NO(;;?KBFWCV5LK<.;^+VTV[,VMCL6-F8C?/RUW+08;K78.3FS
M&8Q>7CWK@L!DZ;/;FQRTC5&W\7740J5%75PTQ]U[I3=__.+!](=QT'1>$Z9[
M5[K["'5G^FS<&`ZTK>KJ3.4/6QSV>VZM7M#;7878NR-R]O;ODR&V*[_<!M.D
MS&3C2.$2I%+78Z*L]U[I.9GYXY+;GR`RO1^XOB_W%M_"X'KZM[JSO<V;W?T)
MB^O<)T-C,_+@,GVWE\76=M0]BX[&XV6"2>HQ,N$7/PP(Q:B#@I[]U[I)R_S-
M-K8':4?8?9/QO^17577V[^I>S^X>C-T[QQO6DB=V8;JOJ[.]T93:F-PNW>R,
MYG^MNQ=R]7[:K\WA</N^FP4U90T52)&@J::>FC]U[H:NA?G)TU\D*[HVEZSI
M]VU,'?'1/8?>^`J<UAH,+-M.BZKWSUQUOO\`ZZW_`(FJK_XQMKM':>]>R(L=
MD,68)5HZS&UL4LJO&@D]U[I![1^?M%V+V/V%L7K;XZ]V;^Q&Q.P>U.G6WUMR
MOZ>JL7/VYU+3;J&6VKNC:C=HKV/U/M_<V<V?58O";EW;AL+@*^LFHY&J8J/(
M8^JJO=>Z"RB_F?UTNS<]O#*?#7Y`X%,=\B:7XI8/$Y+?'QB:LW7WH-_UO7F;
MVKCZRC[VJ<-B,9M[+8Z>:;*Y.IHL?/3Q_P"3R2R,J'W7NIM;_-%V[3U>*V=3
M_''N&?N6H[NW5T-GNIJG>_QNQ<VV-V[3Z3V[\@JK(U?9M?W?%T]D\'7];;LQ
M\T`HL]/D$K9FI)Z6&:*11[KW2JW%_,&S&&WQM_K''?%?L[/]B9#IK;'=FY-O
M0]Q?$S!T>T-N[RWWV)L+;>+FW3N?O[#;7W9F:VNZSKJF3^`U>3I::FE@\LR2
MR&-?=>Z6M'\RM[5/RFIOBS-\1>Z:/,3;8I^Q)NPY=\?'678U)U9/NT;*??\`
M)!2]RS[PEI(,W<-CHL6^6:(:UIF%K^Z]T>SW[KW5%W<W\RKOK9.2^4G8?4OQ
M\ZQW3\5?AOVACNL>YLMF=X9;"]I[LRKR8>/>N8Z_P-#B9-MK0[8?.PJ!6R&2
MMLUB`.%)CU.KLS>(,C_5_LCI';N$Q$JB(5%`,9KU=-M7(8O<&V=O9[#1BGQ.
M=PN)S6,BC@BIA'09BA@R5*/#"HCC;P5*Z@.-5_;+AFU`DU)]<U&.EL95"510
M$T\*8X]4P47S?^77?V;[][4^(WQ6Z*W3T]\>-[[MZ_&Z>W-XY?`]H]LYOKH,
MV[X=A0X3#U=)AH:=$(I?OIOW&*C]3$*ZWB(BIXCD?PUQ0^N.BF&.!W>411B1
M6KJTBM>/'_#T9"I^?^.W5_+2W)\^=B[%@K?X=UAFMYR=;[QJIHZ:+<&W<L^`
MS^V,K7TT&N>FI,C33*DZ(PD158#GWX0^'<"($CNK4<?RZ5.X-H\[!2S#@1VX
M^71;<W_,0^970_5G4?R)^0OQ?Z4C^-78E3UE3U^XNG.U\]E][;'Q7:W\/&V<
MI7;4W!MNAI:REIOXE"D\4$XT-QJ'`][DACF:A)U=-E_I+0>&.T\1]OIZ=6(?
M-+O=_CC\7NV._L=M?!;VS&PMOX[(;9VUN!VIL7F\MF<SB<'AZ"><1S55.:NH
MS"DF)2]EM;WZ!6\545F"^=#3I1<E#;+J5'`R-0KG_4.BF;7^=N]<Y_+!W3\[
M=N=0[&C[*VOM#>&:S76$%;7T^V_O]C;SK]O;BQIS%+1G,F*''8^6I77$3J`N
M+>[2H?J=)9ROS->F8F5H6D"J"00:"G^ST8?M+Y&[7V3\)\U\VX-H[:S-;B.@
M:#N?$4E3#$?NLAE=KT.6Q>"&;-,^2IZ6;)5T=+Y8SY%6Q`OQ[HYE<&$22(*T
M[33'YU'\NFA!:Q69G$:-)Q[@#G_#T8GX_;YW5V?T;U'V1O?`X_:V[-_]>;2W
MGG=N8JHJJO'82OW-A:/,OC:2IKDCK)HZ1*Q4U2*')!N/;4@57*K\(Z7QLS1A
MF^(CH7_=.K]%@^7'QTE^3O5%)U]2[EP^W,AA.P>O>RL7'N_9\?8W6VYLEUWN
M:BW+1[2[4ZXDS>VEWWU_G9:3164`R-%*DRPU,4JRTZ`^Z]T1O$_RM]U;>VQ%
ML?;_`,A\/AME]D;9P^R?DOMC'=*TM'B-T;,P/R%[-^0F'VE\>\?3=@Q4/Q[V
MOAW[AW!M"@QTT6Z:7'[5J*58%2MHEJ9O=>Z,'\>_A3N+I;M/;^Z\_P!O4&^.
MN^G]L=X;(^.>PJ+KL;5S6QMK]_=G;;[*W;'V!O,[PST78F6VY'L_&8+"3TN,
MP,4.*IY)*J*KK)S.GNO=%AQ7\H;`5?9F9S^^MW]-9#868[G^4G;&7GV#\;:3
MKOY(;[PORD'<U-N;J/L_Y)0]FYW([JZTQF,[GJ*>6D@P5#)DEQ&-UO$M,%;W
M7NC,]7_#_N+&;XZ"S'>WR0QO<>R_BE39E^D-OX/J&#K?<F:W5DM@Y?JC&]B=
MX[I&_-WX[?&[MN=:;HR^.@CP6*VMBIZS)39"6D,BTT--[KW28SG\OFJH>EL]
MUMU5V7M;8NZJOYVY/YUX'<^2ZF3-[9I-W5OR*D[^BV?N/9F!WQLNMW'0J[+B
M9LA'EZ&JFBC68*A`B'NO=)#Y*?`+O#Y3;>AQ?:?>_0FYZC.]=93K_=F/W7\1
MQO#:6Q,U49K<M1B>\/B]29ONZ3>O1?=U%MS/4]#5U\^?W#CZZJQ&.K4I*5Z4
MQ3>Z]T8_*_#3:VY.Q<ENK=^[L_O#:>?^&=7\--T;7W"'J\]NC:V4SLN1S>[L
MYO>.M@K*K/YO&U$M/4Z:5&>:5J@2!CH]^Z]T6G=7\NKM_MCKO#=0=X?*RAWS
MU[U9U#VYUKT><%TE2[0W?#N?LSHK>_QUPW;/=^;;L7/8KLG=G7_5_8V9I:>D
MP6.V?B\A75TE=/`L@IXJ;W7NA?ZG^`NWNG?F+D?E?M/L;.18_<G063ZMW7TT
MV'I$V;7=I9W,]03[I[]P58M<:G;>Y]];<Z6PE!GL?%#)29.HHH<@SI6&KDJ_
M=>Z05'_+UW3/\I-D?(#=7<NS=P0=<=M;P[3VSNNBZ*Q6V/E9F,%N?";QPF,^
M/W8WR4PF]88=^?'_`&?3[O\`%1XJHVO%75%!BL92U-7(]&U5/[KW2@W1_+HV
M;OGKNIZOWQN?$;SV?E/GCFOFMN+;VZNO,1N#;FY*3,]GYGLF;J+-;>RV5K,7
MD<0LN56E;(3I*'\(E-)<Z![KW0$;H_E'X.BI=B;8ZDW+T5C>I.HN_>UN[.H.
MC.[/C!B.Y>I]DXWNSKFKVQOGKR3;>.[$ZY.<Q&(WWE<AN+;59-(M3@X:\XI1
M-14M)X?=>Z==V_RS=V[D[`V=V8:_X'Y7,X#H+:71-3LS?GP"7>G4VWJ/9'9_
M:W8&%SG3NRI/D-BZCJY:ZA[-6AR5$*[(QU4N-CJ%>(,((_=>Z/CBN@:FE^2V
M/^262W;35.5A^-U#T#7[4QNW#C,1/4P;^&_:K=M!5RYK(5-!335):FBQK+/X
M8K$U+D6/NO=&1]^Z]UJP]S3T>TOBS_.\ZRR4SQ[PW?\`,K"8+;6"M;*Y:N[D
M?K5MA+0TJ@O5'/A)V@"@ZUA<_P!D^UM:LI'"AZ01#PPP;R/^?K9JZ\PU3M_8
M.QMOU:!*O`[0VOAZI!:R5&+PM%13H+7'HEA(_P!A[3,14GU)Z6HP))'\/5.W
M\G6CJ<A\2?E/CZ*(3UN0^7GRPH:.'6L9FJJK))!31>1RJ)Y)9`MR0!?D^]RR
MI4-Y#HOL^Y)".!/^K_#T#61Z.[.^.?\`("[RZC[BVXFU-_[;ZF[@FS&#3)8_
M+I2Q9KL#(YC&L*[&3U-',*C'5L;V5SIU6/(]O>(LER)5^#_8Z<F4Q6+(_P`5
M/\O^ST]?S%/^W*/2X_!VY\*P1_4?Q'K_`(/]1[TG]LWY_P"'JEU_N$OY?X.C
M3?S9ZU9/B5UULD:2_:OR7^*W7AB+!3/3Y/L_;>4K(K?VPU+B'!']#[];G3+K
M/``]/W&84C'Q-0#H*OY=&R*7>OPY^;7QCR,0E7;GR6^9'3,E"]M46-W+D,C5
M8V)5^D8MGM:7XX'N\YK,)!PI_E_V>JP*?">`_&O'\^'1/LYO7+;]_D4?'7J0
MU#_WL[,[`ZG^(&1IS_P)EK<-W9+L_,492]]<&)VHS$?T6_T/O5/UB?*E>J?V
MEF;=?[0U'YU_S=;,F#Q%'M_"XC`X^-8:#"8O'XBAA0:4BH\;20T=-&JW-E2&
M%0!_0>T9R:]+@*`#IT]^ZWT5#YH_)^#XA='R=Q3[?VSN+R=D].]:P4V]NQZ#
MJ+9&,K.X.TMI]8TFX]Y]D9/`;GHMH[5VU4;J6NKJIZ"HTT\#*%N01[KW13.L
MOYF6<[MP^UMN]-=%;6[*[MW;VEW+U]B<1M3Y"[=SOQUKML]"8?KG+=E]O8;Y
M+8/8V57<?7V%R';.!V]IH=JSY9MV5%1CVHTBHJJMC]U[IGWS_-2EV;BMFXG*
M=+[1V!VC5]C]R=1=I8KO_P"0NW>ENE^L.R^FL5L+/ML=?D#/L;=NW=S;E[>V
MMV7B<YL2F;&XUL[@S55%0<?/1STB^Z]T)^X?F?\`)6D[>^.G6>W_`(?[4DHO
MDEL3+[[VUDM[_)W';8W+M*GV3M78&X>RL'O+;>T^GNRMN',;;K-]?9T#XC<.
M6H,O]HTZU-/%*A]^Z]UBVC_,#W;N2/K7M>N^.-?A_B%W+VY@NG^M^]T[.Q61
MWO4U>^=Z+UMU9V+N[I-=JT;;9ZJ[1W_44=#C*V'<>1S%/!E:&JK\920R5!I/
M=>Z8?BQ_-)V5\HMO_'&KQO4^Z]A;R[N[BW=T]O#KS=.<QS9_J2IP_1G9GR$V
M1O.KDIJ!8-Y;([;ZZV#35V`KZ04\-1!E;,5J*&MI8_=>Z'CY>?,_"?$7<_Q5
MPNX=B97=F(^2OR%PG1&1W)CLU1XJEZKI<[M[.Y.'L3/TU71U+9?;]!E\=24=
M7%')3O!%6FI+E(&1O=>Z+Y!_-'PV9Q'S>J=G]';HW5N#XJ=_[7^,W5>U*?>&
M#QV1^4O:V\ZC$[5VYC-EU60Q\=!M#&UO:576X1ZRJ>MA@I,749)R*=&1?=>Z
ML0Z<[3VOWAU1UUW#LJ:2;:O9>S=O[TP@J`J5M+1Y_&T^0&.R4*EOM<MBI)FI
MJR!O7!5121L`RD#W7NB&8C^87O;=&YJS"[-^+6X=UX[?G^G"A^+F2Q_:NS:&
MM[OSGQZ[5PO4G8D&[,9FL=C*;IS!G(9:7/8VNEK,W)5[8QM74O305ZT^,J?=
M>ZEXW^8M.>O]D;DS7QUW_+N?.?+_`!OP[WO2[#W#@]\]5==[IE[FV=TWF.PJ
MON>2FVUB\YL&@SF]::"F2'&0YRLS453BVQ\$U%72TONO=!MOG^;3M;KJO[+K
M-S=0.FR\)N7Y"=>=29*A[>V%-OCLOLKXU[L38N_,-O#KRM3'2=+;1K]QQU4U
M#N#*Y&JI8,+2_P`0R<>-CJ*-*CW7NCE]!?)JL[FV9W)69#KZ#%]I=!;US/77
M8W6G7_8&V^TL?4[QHNO]H]H8;%;&W^(=FXC/_P!X]H;\Q/C_`(C3826CR$TM
M-5QP>$RM[KW1"<W_`#@\1M/`;BQ6].J.O-H=Q[?[SJ.C*W;.8^4.QWZ<PVX,
M/U&G<N\Z?=G?.,VCD(,1NSKG!R18G/8&AV_E:VFW#5TM/`U3122Y"G]U[H68
MOYF<$>1PFY,QT3E\-T+15G2^SNV^X#V?L3<,_6?:G>?4>WNX-J;9Q^U]G'<>
M([)V7C,1OC;M#D-S8C/-3&NSD!HJ>MI8JFIA]U[H,O\`AU#MK[[^`?[)!N#^
M]7^RU_[.Y_!?]/&RO#_LHWV]O[Q?Q+^ZVG_3S_%_]Q_]R/%_#?N/7_>+[?\`
M>]^Z]T47L&BZE[2_GN[2P5149Y=BXJ@VU4;TITA3_1YO?Y9=1;#SNY-A87(5
M.G[>LW'LK8>=CJ3"2[+/$JD"_M6"5AKYTZ1$`RT/K_/JZGX<_(VH^4O4%9VC
M4[4@V;)3]E]J;`&&I\M_&8VCZXWUFMFQ93[S[2CL^7CQ(J3%H_9,FBYM?VS*
MND@?+IZ'()Z(#_)<KJ'$_&KY!564KZ+&4J_-_P"2(>KKZF"CI4,FYJ%8U>:J
MEBB#2,;`%A<GVFD%4(Z36`_2?_3?YNC'_P`T^MQV7_EL_+ZIQ==19"BGZ:W%
M%'58^J@JJ1R*JAC<1U%.\D)*."&L>".?;\'%1_J\^GK_`/W&;_2_Y1U3SW_\
MJ.NOEG\)_BM\$.GL9OE>X]]GXQ81<CV/L[+]4;$QM)UV-IY/=&2I-X;_`(L%
MB=T.(\:5HJ;&/53UVM6B4W`*E4*N7/#I/='_`!-`/E_@ZLM_F-PG/]K?RQNI
MY+3P[E^:NU=R9"`#BHQ_5&RLSN2HD9&O98YS&_(N/\#[K'@,?E_GZ43X>#[>
MHW\O28[9^7W\UCK)AXQ1?)S9_9]%3H+**+L_85)6RSHM_I)58UM1_J#[U)E%
M/R_R=>@/Z\OVC_+T03K#;Z2_+CK3X6QH%H>H_P":%\C?D7-B@/+!!L.@ZNI>
MT=GS/"05CHFW'V#HBX`$H_J"?;C'L\0>:])X*BX*'R)_U?RZV=O:+HRZ][]U
M[HNGRD^/</R8ZNI>NSOK.];9+#]D=2]J[;WGM[#[8W#7X;=G3?9.V>SML/-@
M=Y8K-;;S&,J<UM:&&KIZFG=9:>1PI5M+#W7NBP8C^7+!MN>;L?:_R-[2P'R@
MJ>R=U=EUGR%H-I]14O\`$9M[]=]<=5;IV%D>GJ#8E#U5/UIF=F]0[9>:C2@B
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MZ"KHJ*.6>IHZ*FI$]U[I%X[^5WUKLC+_`!2[&ZP[`WUM[N7X<].;XZDZ\W=6
MSX:?"]D4.:ZP[!V#L.I[JVW'A'QFYI.J<GV1E,I@I::&FEH9,E7P#735T\+>
MZ]T/_P`FOASM/Y9[8Z^P7:.[-QX^KV-B.S:1LCL^+$4!R&9[3Z0WOTME<]#'
ME,?E?X;7;;CWQ+FL.T1!I<K14SMY$1D;W7NBU;2_E#_'#$#9F)WSEMT]R;%V
MQ7]=[GSG7O9U#M#.;8['[%ZTZ/K>E,%V-O\`@CV[339O<E1_>#-;GJ;-'3ON
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M8S>;3(/=>Z!S<O\`+%Z]W=V]W+W)F^T=W-NCLS;_`&=A=KY/']?]%8_<_7E3
MVUBZ7";CR%?O2/JY]Q=R4NWL!3R8;;N,WM)G<9BMOUM5CI(*J%XC#[KW2GZ=
M_EH_';JK9_\`#:K$46X>R1N+>.\,;W#A=G[$ZNW-L+=6\MH[<V%+D^G<!UIM
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M[S_+/[]>/^\/W?-_#^Q[]U[JLWK+$YRM_EJ9#YD8J"3*=M=#_P`Q#?7RNRV3
MD)GR6:H\#V=3[+[$H:B<C7)2U?7$LT3+R%@IE%K`^UFK]32>!7HGMB?W<Q''
M4?\`#U;%_)[K*;*_#9,]0'7C=Q][_([<.+E/'EQN8[DW;644EAZ1J@D'TXX]
MLS_'^72NPS;_`)GHGO\`+6ZEZV[O^"7RTV-VUM#%[VV@_P`Q?E!FIL#F!4M0
MOE=OYN')8?(,*6HIIC-05E.DT=FL'4&WMI0"17UZ:L_]QIOSZ!#J1RW_``F[
M[5YE.GJGN^,&:5Y7M%V?F8U&N1Y&TA5``N;`>UKT^L7IB'.VO7U/^3H:/YBU
M'1R?R8_C[FIZ=)LQMO&_"W+[=RQCC_B6$RHJMBTBY'%U/ZZ*J^WJ'C+(1>-B
MIX]ZB-;T^G2B[_W#3_:_X.E[\^.[=H]7?/\`_ER9OL"DWAE]M==;&[Y[-RE'
ML79>XNP-QQY+,;5QNRL/7#;NUJ+(91J5JRJD5YQ$4C/)/NB`LC`>9ZLQ/U4=
M>'AC_">FCX+]\['[;_FL_-#</7]%OC#[7[3^/W2V[H:'L'8VY>O,]/G=C5C;
M4RTZ[>W708W)M2B'()HG$?C?U6)L?;<X(MP/,$=>5O\`':>JG_/TINO]F8"F
M_GT=\YR*D*U[?#+9.Y`VJ\*YG+9K$[8R%='']%GJL1AX(G;ZD+[K*?\`%Q^?
M7@/]V0_TO^3J\7VWTOZ][]U[HO'R/[BW!T=@.M-WXW`8G-[9S??/3G6'8]7E
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MA14DU"*>JIJO`_&W>D,U3,R5HJWQ*)"6JROOW7NAC^97SP[3^*^'^(5#N>7H
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MXP19;LWJ[Y';'["R79>R^K^MNN=T4W;NS<9MKMO96Z=T;^H:/+=C;+2?;.`G
M"2+%7TE;2U#>Z]T^=R_S%>_?CEM_Y"83L[*_!W=?;74NR^JMX+A.M>RNP9:W
MKQ]^]S=3=7;@I.UNI,C15O:66VGMG"]N4.9I=QX98UR&E:2;'T,]12?<>Z]U
M'VA_-/WE4]#_`"?[*R<'Q\WW-U?NCJKJ;HOMK:6=[%ZM^/O:?R![DW%7=>T'
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M#UKMB#L7`[=Q5'C>P:O<W8N<[<PU+3[8JZZE;"F+(33Y*KBIZ7[_`-U[H!MK
M_P`TW>5/\DN@.A>V.K-D;*QVX\K\INK?D;OO%[RRV5VYUGW'\?LIMRDV=D-H
M9'(X;#G,]7]NX[,13TTV0IZ3(8ZIRE'13KYXYBWNO=!W_P`.Y]O_`/#?7^SI
M_P"R[X+^\W^S;_Z'?]$W\?S/WO\`H;_TB^/^]/W7VOW'^D7_`$-_[E/L-'VW
M\6_R?]''OW7NG;^5MC-KYG^6=WGM/>JTK8"F[)^76#WW25Q6)<?CY<QG*S)Q
M9!)O^`DD.,JUE/D`TJ0W]/:EZB12/ET66B*;1XC\-6Z?/Y#&]C7?".FZIR=-
M]ANCIK>^6QN2I97=JJLV[V)3T79^Q]Q.)+.T6;V_NH%9/TR-`Y''O4Z]U?E_
M@Z<V]NUH_)3_`(>F[^4+H/P]^6JHVIU^6'RX66->6AF^\L87'Z@P!!Y`O?WI
MT".H'6K=0D,RCY_X.BD]1?\`<-WVO_XBSO3_`-^GF_;[?[F+^72:#_DFO]I_
MR=#E_,4N?Y*/2H"EK[?^%8('U`_B?7^H_P"P4>Z1G3<E_//^K^?2J0>)8J6]
M!T9#;TW]\OYRE0%.N'IO^7[A:9R3_P`!<CV/V9!5`17_`$F:@H`6_J`/>F4"
MWU>9;JP%;E#_`,*_S],O8K?W*_G>_'G*7\--W-\,>S]FS2EFM4Y#8FZ_[QT]
M,W.EG6%[CCWX('M23Q#=>90+Q6^7^2G6#9'_`&_.[W_P^"G7/^P/]^AP?="@
M>``^O^7JJ_\`)3`_H]7->V.E_7O?NO=!3WGTQL?Y$]/=D]&]DT^3J-C=I[0S
M.S-R?P/*U>!S])09BE>`9/;V>H&2OP.XL/4%*O'UT#":CK(8YHR'0'W[KW02
M[6^%'Q[V=V]MONO!;3JH=W[3^,.(^(&%HZC+5=7M6#I+!YJ#-8[#S;9G+XVI
MS4;4RTK9%U-4]!>G+>(E??NO=!WUY_+;^+?6..^(6,VU@-VRP_"'.=H;CZ.F
MS>]\[FJQ,QV_0YNDWK6[YJJZ:27?4E35YQJ^G^_,GVN1I:6HCL]/';W7NHV:
M_EG?$W<&U^QMGY?:6XJS"=I_+/"?-#=D4F[LN:B3N3!YG;^9AI\94F0RXKKZ
MM.!:EJ<!"5Q\U#DLA#I"UDM_=>Z,;DN@-EYOM;9'<F>R6[<WO#KBK[*GV4N1
MSQ?"8*A[7V[M3;6Z\##B(*6""IP9I-H4\U+#.96IZJ:>0.?)I7W7NBY#^7'T
M=A<5M&@ZSWAWGTGDMAT>^=L;1W3U'VGDML;DPO5>_MWUN^*[I"*IJZ++XZKZ
MDVMGZYFVOC:FEFGVE`BPX:HH8M2M[KW0X=*_%/I;X]Y@Y?J?;^0VT/\`1%UM
MTG'C9,]E\Q0+LOJS=/:>]=NSSMF:JOR.2W5D=T=RY^NRV8K*BHR.7JJSS54L
MDNIV]U[H-\+\(-H;7[:WAVIM/NGY&[8I.P>TY^X-[]3XGLC'-T]N?=N1H\)C
M\]%DMI9':F0K?X%N2BV_3QUU'%711R@OIT%R??NO=(/`?RP?C+CH),'NJH[<
M[8V!C.M-[]-]<]7]L=K;FWCLCIGK'L.+$TFYMJ=6)++1[FPB_P`+V_CZ'&Y"
MLR>0RV#H:&"#&U5(B6/NO=3D_EP=-92:MK^R.R/D;W5G3AMK[7VYN+MON?-[
MGR^QMH[7[8ZQ[K3;6TVI*3$4$,6X>P>FMLU69R-;!6YS+1XB"*HKG0$'W7NA
M#W1\&/CQO+NJ7O#<>VLCE<M7[JP78>X-A5^4.0ZAW5V?MGK;>'4&#[0W+UOD
M:>KP&4WY0];;REQ7WQ5?-%C\;+*CSXZDEB]U[IRH/A=T1B-MY#9N#PF7P.T*
MWY*[3^5U'M;"9J?&;?V]VOM#=6S]]T8VQBZ6..EP6T,IO?9D66K\1`JTE37U
MU=*0IJG'OW7NE!W1\8]E]Z4BINS=?9N&S6%WO@NQ^MMX;(WI4;4W=TYO3!;8
MKMF_QCK+,8^D)Q<6=VWF<E1Y:BKH\CC\K2Y2K@J8)()C$/=>Z!E?Y=_2]'MS
M;E-@M[]\;9[0VUO'?._HOD;A>U\K_I]S6Z.SZ;!T'8TVZ=WY.DR>$W)@=X8S
M:N'I9\'5XJ3`TL.$Q@HJ*E;&T+4_NO=)'?/\J?XB=B]<5'6&Y\/V-5X3([%W
M9LC.YM.T=W?WYW+4;][JV5\@]\;^W#OF>NGW/E.S=V=I[$I*ZLS3U/W#02ST
MB!*600K[KW0X?[)5T/\`W:_NA_!<S_=S_9D_]FJ_A/\`&IOLO]*/\?\`[Q?;
M_;>+P?W+^\_:_A&G[7[7]JVGW[KW6M/V[_=;^\?\QG_F=/\`!?\`2_G?[W?[
M*Q_ID_V0O[S[>G\G^S66_P!__P#QG_GL?[C_`.0>+R:/:T\5X<//CT76W]F_
M"FH_9U<+\#/X7_LWWR@_AO\`HXU?[+Y\*?N?]"']\?\`19X_]&62_A^G^]G[
M?\6^T_XM7VG[O]W/MOO?\IO[I+\'GQ/'_5_JQUZRIXSTT\!PK3A\_/U^=>JG
M8OX#_I2^?W\!_P!FR\?^E7>G]ZO^&R/](_\`LO'W?VE7YO\`3)_I)_RG_2->
M_P#>+^YO^0Z?-XN+>]R_"M?4?;_J]>KQT\.:G\OLZ-CL;^['_0/1V/\`PK_1
MM_=[_0OVCK_N=_I?_N3?^^^1^\^Z_OE_QD_^(_<:OXAHX^\\GVW[&CW=_P#<
MQ>/ETDB_Y)K\*5/^3H2?Y@/\*_X9LZ=^[_@G\-_N]\.O%]__`'R_@]OO]C_;
M^+^"?[^OQ7MX?-ZOIYN-7NB?VS<?/_)TK/\`N`/LZ,+\?_L/^'7OF3XOX7_$
M/]ED^,/G\G]X_P"._;_;Y/P_:?=_[]G^[]_^5?\`RK[F_EX]^D_W&'^G/5T_
MMU_YI#_#TR_+#^'?\.I?RT?/_#/XA_=KY&_9^/\`O3_>/Q_W6I?-H_A_^_9_
M@MK?<_?_`+NNWB_/OT7^XK^E?\G7G_W*3[#_`)>N.R?X?_P]GWAI_A/\2_V2
M3KWS:/[S?QG[?^^:>/S^;_?J?:ZOT^#_`"J_Z^+>ZC^R'V_Y>J#_`)*8]:=7
M">TW2[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
CW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tex10-1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tex10-1logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`,0$Y`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`(ONC^8U\^Z7<^Y::G^9OR1@IZ;<.;IZ>"+M?=*10P0Y.
MJCABC05EDCCC4*H'``]]`+?DODYK>-FV?;RQ1:G0?0?/K!>?G'G`3N%W:_`#
MM^,>I^72AZK_`)K7SWZS[+V'V#7_`"=[I['QFS]SXO-Y?8&^NP,YGMI;TPU-
M/IS&VLUC,C43TLM/F,9)+"LA773RLDJ$.@/LNW_VRY/WO:)K"#;K*VNF7L=4
M-=5,>>,TSGI?M'N#S5MFX0WEQN-[/`K=ZLZTTUSY9QY=?1)Z#[PZ_P#DGTWU
MWWIU=E!E]B]F;:HMR8.H;2M32?<!HLCA<G"K-]KF=OY2&:AK8228JJGD7\`G
M![<]MO-HW";:]P71>P.49?F/,>H]#]G69FW[C:;I9Q7]BVNTF36K?+&#Z-GA
M\CG'13OYL6^MZ=9?R[/E/O\`ZYW7GMC;XVOL3&5^W-V[7R,^(W!@ZU]Y;8I'
MJL7DZ0I544[TM3)&61@VAV'T/L3^V]C97_/.VV5_"D]I).Y96X&D9H#Z@XK^
MSH*^X-]<[?RCN-]8L8;R.&,*Z_%EQD>A'EUHQ=7?S$?GIENTNK\7D_F/\CJ_
M&Y/LK8&-R-#5=J[HFI:['Y#=V&I*ZBJH7K=$U-5TLKQR(;AD8@_7WE_O?)/)
MHV._DCVG;TNDL9F1@AP0O'CY>76,7+_./-S[U903[E>S6\E["&5I`,:C\O/S
MZ^E:RA&<`6"L]@/H!J)L/\![P)&E5I@*!Y8`IUFH*MPJ23]IKU0)_-+_`)WV
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M6HM7W/DIYEG45:W<Z@?4QMY`\`A]..>ICY/]Z[M+V+;>:O"^GE:BSHND@T&)
M%)I]KCC7ACK;FW+18CN_J#,4>S=\UE!A.T-B5B;4[)V%FI*>NHJ/=6"D;`;S
MVEN#&3*\<U**V&LI9XG%](_!(]XU6LDFV[E'//$K-;S`LDBU!H<BGSX?MZR"
MN8DW.PEM[:5@)HB%>-J'(P017KYTG:/S4_F6]+]E]@=0[Z^8OR7H-X]8[QW!
ML;<E,W:VZU7^*;<R4^-FJ8;U@UTF02!:F!OH\,JD<&_O.W;N6>1-WVVWW*QV
MG;FBN($<'0>+#-<XH>(ZPLW'F?G?;MRFL+C==P5H)62FL<%-!3&13@?/K8W_
M`.$\7ST[.[\C[[Z`[^[0W=V?V#MM\1VQL'<>_<_4[@W#4[-R`I=L;LV_#D,C
M+)6ST.WLW%0U4<8+",9-[6'O'OWPY0L=@O;;=MK@BALI`L+K&A4+)Q\R:J?7
MY<.IU]G.;;S?K"XL-UFFEW&.0LID8-JCP!2E*&OR\^MG/W!/K\B1^S'4ULI4
MZ3QZ#GN#L_;72?5/9';^\JA*7:W6>R=R[XSLLCI&&Q^V\359.6EC9_2:BN:G
M$,2_5I)%`Y(]J]NL)MTW.WVVV!,\TJJ*?,T)_*M?V])+^]CVS;Y]QF($443$
M_;3'7S?-T_S0/G]NO<^YMUK\N._=M1;FW!F]Q1;<P'9.X<3@=NT^8R55D8,%
MA<91U45)C\5AX*A::GBC552*,"WO/FT]O>3K.&.Q?:[&9HXPID=268A<LQKQ
MKQ/6$EQS]S=-=/>_O*^BC9R?#C8:5!-`JBG#ACK='_DD8/Y!5?PNP?<WR3[;
M[/[4WSWYFJG?NW5[*W3FMQ3;4ZUIQ)AMF46+AS$LG\/_`+QPTLV7F:,*9DK8
M=5PB^\0?=2ZV1^;Y=OV"U@MK"TB2/]):!WH2Y.36AQ7K*7VTM=XBY7BN]\N9
M[F^N.X^(P;2,T`H!2HR>K'/D/WCLKXU=']H=\=AU'@VCU=L_*[KRD2/&M3DG
MH8M.,P5`)"!)D]PY66"AI5YU5%0@]@S9MJO-ZW:WVJQ#?43R*H(%:"M23\@H
M)/RZ&&Z[K;[)MTVZ7+!8X8R<^9X`#\R!U\ZC?/\`-(_F`;WWKO'>X^5_>6S8
M]W;ES6XTVEM'L;/X7:FU*?+5\]73;<V[C**HAI:+#8.GD6FIT51>.(,;L23G
M98>WG)MG:1[>FUV<\T**K.]7=VT@EN(I7T]>L*K_`)]YPNKE[UMRNK>*5F8!
M"%4"I`\C4]*'IO\`FN_.OJWMCKKL7</R9[O[-VYLW=^&S>Y>N]X]B9[-[:WK
MMNFJD7<&V\IC:^IEI9URF(DFCA9EO#4&.06*`^T6^>W/*NZ;1<6%KMUI;7;Q
M-HDC4A@X&,DF@)X_+I;L?N#S5MN[07MUN%W<V:R#Q$=@RE">X@4R0,CKZ,/5
M_9.T.XNN-B]K=?Y),QLCL7:F"WEM;)II'W>$W!CJ?)432(KOXJF**H\<T9.J
M.9&0\J?>"EW9R;=<R;;.I6:W=HV!]5/EZCT/69]G>1[C:I?PD-;S*'0_T2`1
M4>1]1FG5+_\`/MH/DKLGXR;?^2WQJ[I[5ZIKNE]RT]%VCCNNMXYK;=-N'KS>
M]318:+-92EQ=1%'556T=T&C*RL`T=)6SDG2MA*_LS/L,O,,NR<P6=M<Q74:B
M%I17]1/(@4I45SGAU%_NXF]6NPIO6R7=Q;S0.!((B!^F0:YH:T-/V]:>O_#D
M?\P:)DFA^:/R0,]/+'40"?M3<\].TT#"6):BGEJWBJ*=G4!XV!5UNI!!/O*A
M^1N36#0MM%@E:J2$-17%1GB.(ZQL7G3G)"LB[K?/P8`N*'SH<<#P/7T4?AWW
M[AOE'\7NC>_L(R>'LWK[!YS*4Z%?]QNZ883B]Y8=PO"28C==!64Q%A;Q_0>\
M$N8=G?E_>[K9)`0UK.ZCYJ264C[5H>LUMBW>/?-FMMUC-?J(48_)@-+#\FQ\
MZ=&4]DI(45/#HW`J:#CUKY?\*"_F[O3XR=#]6=6],]@;CZ[[C[CWNV7_`+S;
M.RTN%W-@NM]@K!69V2CR5*5K*`;@W%7X^CUQLIE@CJ$O;4/<V^R?)]ES#O5U
MN6[0Q3;=:PM'ID4L&DDX`4(P`"2?+'4.>\?-5[L6R1;=M4TL.Y79U!HV"E52
MGQ5KQK@?+K65^-?RG_F4?*#OSJ3X^[/^9OR9.:[6WMB=K_=1]K;KD7#X:61J
MW<VX)]-8VBGV_MJCJZUV/%H+?GWD!S7L/(G+O+]YO<NSV'@6Z``*I#EG%$"U
M/&N3Z=0?RYOO._,&_P!OM";I>N\KKJU,"FGB2U!PH#^=.OHQX+&0X3"8;"T]
M5D*ZGP^*QV+@KLO6SY++5T./HX:2*LRN1J6:IK\E5)"))YI"7EE9F8W)]X)Z
MGDD>63!=B=(X*/(#K,Z-#&HCK55514\20,D]4(?S]OG[NCXK='[*Z7Z7WKD]
ME]Y]Y962N;<>VJ]L?NK8_5NU*N&3-YW&UU/_`)3BJS=6<\&+IIU*.T`K"ANE
MQ-'LAR9:\R[Q/NN[0)-M%FI[)`=,COV@4''34M2OH3U$ONUSC><N[7%M^U3/
M#N5RV6CH&15->)X:J4ZU'%_F/_S`!91\T?DH+"X`[9W2+`6'`^]^@X]Y1'D3
MDT!3'L]@49J5*'!^><#K'.7GKG"5B6W>_#JM::UR*^6,GK8._D!_S+>U.R^X
M]_\`Q:^3';>\.SLYOW$OOKI?<W8>?J]P9N#.;8HV7>6PZ;*9*22H-)E-OI'D
MZ.GUE5DH:K2+R<P)[V^WNW[?;6_-&PV\%O;Q?ISQ1J10M72P)K48SPXCJ:/9
M_G>^W*XDV+?)FENRI>)B.*K34&/\1K@9KGK:+[EZWD[=ZQWEUS!O3>O7-;NG
M"U./QF_NNL]6;<WIL_*E3)C-Q;?RM#-3RI68RM1)#"[&&IC#12AHW8>\>MLN
MCMNZ0[FT4$\24)21*ZAYJ3Z$8^1R.IVW*Q>_LI;,2M`SKAUX@^1_(]?/[^7'
M>G\U7X7][;OZ%[<^87R53.;=E6MV_N.D[1WC%@-_;,KY9?X!O;;4T]9>7&96
M*)DEB),M'612T\MGC-\W>6-I]NN:]EAWS:=JL#&RZ98_#-8I>.EN[C0'Y$9Z
MP\YDW7GSEG=I=IW#<]P$H:L3EQ^I%_$N,K6F?7H]O\G+^<7VIL_O\=*_,7N#
M=G8W6?=N0Q>'VKV+V5N2HSF1ZN[%8BBPR5>:RTC30;%WB9$HJI7D\=#7"GJ!
MIC>H/L`^[/MA8S[.V_<K6J03VE/&AB!TR)\6NF:%!Y>=.AO[8^X^X1[B-AYE
MNGG2[:L,TA&N,C'A_,.W#TK3K=6R>3Q^%QN0S&8KJ/$XK$T-;D\ID\E414F/
MQF.QU/+5U]?7U4SI#345%2PO++([!4C4L3;WBN@,CK%%W3.P`498D\!3K):1
MQ%$9Y>R)5)).``!4D_+K06_F+?SFOD/WU\DMQY#XP=V]G=-=";)^XVAU[2;`
MW/DMI3;]IZ*J<Y+LC<O\-DAGJ9]RUB:L?!*2*/&)"+"5YB<S?;[VKV/8]A$G
M,5G:W.\7%'D$BDZ*\%J"`2!2N.)/6)/._N7NV\[RR[!<20;;%549!1VIYCTS
M6A].CF_R:=J?S#_G)V6O;?;WRX^3<7Q3ZOSJP;ACG[;WA2GMW>E$D593]=XB
M:.M1WP&/,D4V?J8V&F%DHT82SNT02]V[_DWE6P?8]HVG;TYIEIG0:PH?Q&K&
MA;\.#6A].A1[86'-_,-_^^-UW2_?98.`UC3*QK@&F=%.[A2HZW*5````"@``
M`?06%K#Z\>\70"!0T)^0H/V>761XX>8^TU/[?/KOWOK?7R9]W"^[MU_^'-N#
M_P!V]9[Z5V*J\4$;,$#*HJ?]+P_/UZYZW#K'+-(Z%PI<T!I3NX_.GIT+W<7Q
MTWQTSL?X]=E9N)ZW8WR2ZI@[-V%N&"EDAHC/29?(8'=6T:F1F=/XWMG(T,<D
M@N#)25D$H4!B`3;)S#8<P75]:6#:+ZPF9'B;B:4HX.,-Z>5*='.^;#<[%!9W
M5RI>PO8E=)1PJW%2/4=7R_\`"=[Y^?Z*^SLC\)^S<Z(-@=Q9*?.]+5V2GM2;
M7[8,0;+[0ADE=8Z3'=C4%,)*=!Z?XQ3!5&NL8^X3]\>2A=P+SAMJ^)>QJ!<H
MHSIH?U"?,*:`_(U.!U+GLUS=]'._*VXL8[21B;=B:@M44C`\J@D_EUL.?SF[
M?\-?_,6W_/N,7_[W>T?<+^TYU<_[4WK-(?\`JF>I3]SO^5'W0>D<?_5P=?/#
MZ>_YG#U#_P")8ZU_][;!^\W=[_Y(M_\`]*^X_P".CK$SEO\`Y+UA_P`]T'_'
MCU],?YW?(>3XI?$GY`]^T:4\F;Z]Z]S-=M.&K*_:U&]LJ\.W]ET\Z,"987W/
MEJ5G0`EXU8<>\!>3=D;F7FBTV'RGF6O^DJ2W\@1\NLT>:]\3E[EJ\WAC1HHW
M"_Z?@O\`,]?,'SF<SNZ,SF-S;HS%=N'<VY,KD<_N//Y.>2JR6;SN8JY<AELM
M7U,S-+/69"NG>61F))9O?0JVMH+2RAM;50EK$@15&`-(I@?/K!:>:6XNI9KA
MB\\CERQR3JR*GY=;1G\A;^5=U5W9LJJ^9?R5VAC.P,`=TY3;?2'6^Y*8UFU*
MMMJU/V6X^P]T8>=#0[D5<\DE!C*.H$M(C4<\TD<C-"4QK]YO<C=++<5Y3V*=
MX&C75.R&C$'@H(R..?Y>?61GM)R'9SV!YDW>)97<_I!A4`<*T/\`JX];?6'V
MGM7;V-APV`VSM[!X:GC6&GQ&'P>*Q>+IX54((8,?0TE/2Q1!!;2$`MQ[QKDE
MN9Y#-<3322L:DL[$_P"'J?$@@10B(@0>05?\W56?\QW^4Y\?/FAU/N^MVOL#
M9_7?R1Q6'K\GUMVCM?"4.WJO);AIHFJJ;;._8L-#10;HVWN&6+[:1ZM9:FB:
M43P.K(4>0^1?<;>N4MSB6:>6;9I'"R1NQ8!3BJD_"5X^GD?4`+G3V_VCF7;9
M#;PQP;JBED=%"U(R0P`[M61]IK]OSO*VBK\56UN+RE)-C\IBZVKQF4H*@:9Z
M#)XZIEH\A0SK^)Z.L@>-Q^&4^\Z8[A)%2>TD)CPRE<'(!H3^(?Y^L+W@=97@
MNXQKC<K0YX'XAZ=;I'_":CY39KL'HSMGXM;JRE3D:GH3,8?=G7GWE0T\M+UO
MV!)DHZG;U/Y&,B8_;6[L5420H/3%'DUC6R(JC$3WXY8CVCF"VWJU4);[A"68
M#X=0/\B<8^765OLIOYO=ADV:1BUQ8OI!.25/J?/[>B`?\*2/B8W77R$V!\L=
ML8SQ;4[YPL>S=^RTL)6"C[7V+0J,?7UC1J(UGWAL?PA"?4\N'F-RS'V//8CF
M9K[9Y^6I"/J;0^)'_P`TW.?M"FOR`(Z`OO5RXEENT._H"+>[&EZ?Q**5^5<$
MGS/53W\LGY+GXG?./H+MVNK&H]HONN/K_L=]16$]?=C^/:V>JJ@#AHL%/64V
M4Y^C4`-Q]?<D^Y7+YYHY+O+!%!NXU$L9\]2&O'SJ*BGG7H">W6^+L'-UK<NQ
M$+_I'TH?7RK7SZ^F,"K"Z,'7G2ZD,KBYLZD$@JPY'/T]X"1Z3@5^(@U]:FO\
MZ]9ND`O7\)(/Y'/^7K72_P"%(/R;_P!&?Q0V=\=,#E#2[G^1F[T?<--3RA:E
M>K>O9*3-YL3*K:UI,WNJ7%4AOZ98EF7D`^YR]A]@7<^9FWR=-5E9+BH_T1J@
M?F`"?S'4+>]>^-8<OKLMNVF[N6)_VBT_D:T_+K41^&?QNS7RZ^473'QZPT=1
MXNP]Y4%-NBNIT<G"["Q.K,[[S4C1@F):':]#4Z&-AYWC7ZL`<F><^8/ZL\MW
M>\R`+*BND8.?$D.!_AZQ[Y3V1N8^8K;:T[48J[FG!//_``=?4$V[M["[1V]@
M=I[;Q]/B-N;7PN+V[@,52((J3&83"T4&-Q6/IHU],<%'0TT<:C\!??/F2:29
MVFG;5.[LS5XU8USUG-%"MNBP1+I@1%5?G0=:BW_"DSYK?Q;/;%^#6Q<NQH]N
M-C^TN\S1SCQ3YBIAU];[)K##RYQE&\F:JH')`DGH6(N@]Y.^PG)Y6VGYTW)=
M+,3#;#S)'QL/M7%?MSUCK[W<R>+<P\KV;`")1+,/X@WPCCY'/5;?\D'X1XKY
MB_+R'*=AX"GSW2?1&'.^NP\;DH/-B=S9O*+68G8>R:Q'5HIXLGDUGR%1&?K2
MXQU-M8/L:^\'-YY5Y=2*P<Q;W=R:8V4T(5*-(Q'$DJ0%/D?6G0-]J^6(>9-Z
MD?<%\7:+6.LBG@2]1&%-,`,"6'F/3HC?SC^,>8^'7RL[F^/N32J?';+W3+4[
M'RE6K:L_UQN.-<[L7,K(?14-+@:V.GG920*RFF0^I6`'')7,4?,G+-GO\-"\
M@TL.-)$%&!_//S&>@CS5LLW+G,=WLLE*)D8P4<]I%?EP].MG+_A-K\U&W7L+
M?7PDWSF@^<ZS%9V3TLM=47FK>NLQ7JN]=JT+327<;.W171UT42W*TN5<`>.#
MTXX>^O*36&ZP\RV:A;.[.F6@P)!Q/]'4"!^74_>RO,S;CM\W+URU;FV&J,_T
M3@#YT(_GULM=I];;3[CZUW[U/ON@CRFS.R-I9_96YJ&1483X;<>,J<76&/6K
MA*F".H\D+@:HYD5Q8J/<%65_<;7?P;C9MIN8)ED7T[#J(/J"H/4R;A80[K8S
M;7<"L5Q&R'Y5'$?,<1\^OEO]^]+[J^.G=O:G16]HI8]R]4[XSVS:Z>2)HADZ
M;&5CC#9Z`-PU)N+!R4U?"P)5HJE2#[Z*[1NL/,.TV^\6]/I[N%76AX!A\)/\
M0-0?.HZP*W3;YMCW2?;I@1);S,!7T!Q]N/V];9'_``F7^2\6?ZM[O^)N;KV;
M+=;;B@[=V'33RZVEV;OMH<5NZBH8V:Z4V#W?CXJIU46#Y@GZD^\8??S8VAW6
MTYG10L=Y%X;TP/$B-`:>I6GVTKUD=[(;PDFV77+K,6EM)M:UR?#D`-*^8#5^
MRM.MI4`G@?4\#Z?4\#Z\?7WC\:4[N'4Y$M2J?%Y=?.@_G2?)Z/Y0_/WMC)X;
M(#(;$Z?-/T=L62&<S4<]-L:IK%W9EJ2Q,/CS&^:S(.K+^N".(DFPMG7[5\NO
MRWR7:QSJ!>7B_5.:9_4[4!]*(HQZD^O6&7N?OB[]S?<20L3:VI%N@_TG<Q^=
M68Y]*#RZM:_X3/\`Q-?*;H[:^:6YL>IH=M4]3TIU-+40?YW.9**@RO96X*)W
MX#8[%M18M)$'UJZI+\,/<7^__,[?XORA:&GP7$WS`!"K_.I'R'4B>QW+I4W'
M--R*A_T(_D5XG_)7K;PSN;Q.V<'FMRY_(4V)P6WL3D<[F\K62+%28O#XBDFR
M&4R-5(Q"I345#3O(Y/`53[QGBBEGN([:$$RR-I4#S8X`_,XZR%GGBMH7N9L0
MQH6;_2C)_EU\RO\`F"?+?*_-OY8]J]_53U,&U<ODH]N=7XBJE<G`]6[6\U!M
M*D,3'135.3@\F3JU4`?>UTI]]!N0^6DY3Y3M-F=0+K5XDQ`RS.!7/H.`'E3K
M!KG?F9N9N9[K=ZDVFCPXAY`(2`2/4^9\^K9MC_RC)=P?R4]U_(Z3;[GY'97+
MCY/[31J.;^-KTEM+'5^)_N''$RK,!NK9<U=N1(]+"2J^S!%TO[B5O=$+[OKM
ML4A_J^0+4)J&GQ=1)<^I!*K^WJ3O];I&]K#N#1C]]_[D:J'5H*@::>F-5.''
MJ@;J7M'=_2_9O7G<G762..WKUINS`[YVK7([I"V2P=9%70TM5H(:3&96%6IJ
MJ,\2TT[H00Q'N<=ZVBVWK:[G:[U=5K)$P8<#0B@*GR(8BAZAG:-TN-EW&WW.
MV:DD,JL?F`<C\^OJ$?&7OW9_RDZ#ZJ^0.Q'_`-^WVEM'';D@HG=9*G"9*1#3
M;@VW7%0`,AMK/T]30S_3]R`GZ$>^>V][-><O;M/LE\*7=M(4/SH25(^14CK/
M3;-RAWG;H-R@RDT2MZY(R.B?_P`T3^7-LK^85T34;;7^&[;[RV'%79OI3L2I
MCT#%9F2-7K=H[BFBC:HJ=D[O\"15D=G--.(JJ,:XBKBGV]Y\NN1=V\<ZGV:9
M@+B/R(K\8S0.N:-Z$@\<!3GSDJUYRVHQ`*N[PJ3`_`@T^`GS0\:>H!\NOG4=
M@]?[RZLWMN[K/L?;>2VEOC8^=R.V-V[9RT1AK\3F,;,U/54TEKI+#)I$D$T9
M:*H@=)8V9'5CG-M]_8[K9Q[C9/XFVSJ&QP93Q5O7':>L,;NWN]MNGM+M?#OX
M&(S\2,OXE],]PZM=[8_G*_(/M?\`E\[/^$^8-9'N6EG.T^RNY/XI(V;[#Z:P
MD%&=I[.K-+"M3-5K)]IGJQFMD:"BB4W:JJO<7;+[3;-M?.DW-5$:TU%X(:8C
MD)J2WJH'P+Y$U\AU)6\^YV[;KRE#L*ZUE(TS2GC(@`H`>(-<L<U_;T6C^7;\
M".P_Y@??>+ZNVRU=MWKS`"ESO<O9B433T.QMG-,46DHG<"DJMY;I>-J3$4C,
M29"]1(O@IY3[$G/_`#UM_)&TFZN#XVZS5$,?J3@:OZ(/G^71%R-R;<\Z;J+6
MW)CVZ*AFF`H%8<80/XF'XOGU]'CIOI[KKH'K+9G3_4^VJ#:/7^PL'28#;N"Q
M\:K'!2TP8RUE9*%$E?ELI5/)4UE5*6FJJJ5Y9"68GW@IN.XWV\7TF[;HS/N,
MS$LQ-33\(XG`'`>0ZS-VZTMK"RCLK*,16D2Z5```-.)H/,^9\^/0F^T72WKW
MOW7NODT;N_X^_=?_`(<V?_\`=O5^^D]O_N+'_I$_R=<]I_\`<F3_`$S_`//W
M6ZQUK\'</\\OY#GQBZQACIJ;M#:W5<N_>E,]-H0XWL/"Y[=@IL/4U!`,6#WG
M0R2XNM&H*JSI,06A2V),W-\O)?O#?[D:MM[WC).GJAID?-3G\J>?64]ORM%S
M9[5V%B.V^2S1H7]&ID'C@T`Q_DZTI"NZ]@;J99$S&S-][&W(59'$N-W#M+>6
MU,MRKJ=,U!F<!G,?R"+QS1?X>\LI?IMQL_#B*2VES&1J!J/#?M<KZDJ2!Y?/
MK%FM_M=\'35%?6\@-#BI'D?E^76Z!V?\Z,5\\_Y"GR9[%KJB@@[<V?USA]B=
MX;?HRL7\.WUBMY;/*9^GHR1)#AM]8SQY2D(&A&EF@!+0/;%/9^3YN3O>2PVL
M!OH&N)&MF8?VD7AL<>54^%_F/,=9.;US)#S5[47VY*0MUX,8D3S#++IK]C4J
M*]:<G3W_`#.'J'_Q+'6O_O;8/WE)O?\`R1;_`/Z5]Q_QT=8[<M_\EZP_Y[H/
M^/'K?8_X4#+DV_EB]R''>7PIOGIULOX@3_N*_P!)>`27RV^D/W;0W)X^GO#C
MV5T#W`M=1`;PIZ5_TK<.LHO>-6;DF95!-)X2?LU?['7SXO>;G6(77T>?Y+KX
MN3^6!\0_X08?`NP,TE6L)6RYB/L'>2YL3!>14')^0O?F_O`?W0#+S_NC,"-5
MRHS_`*7!^P^76;OMW(AY,VP`U_Q5A7YAAC[:UZM!]@?H9]<XS:1/^#I_O+#W
M[R/V?Y>M%2Q%/M_8#U\L#Y8MBY/E9\GYL+X?X1+\B>ZWQIIR#":,]D[D\1B(
M)4QGDK;\>^BO+6L<O6`DJ)!9PU^WPUZP#WMT?>;LH:K]5+GU[VZO5_X3$)6'
MY=?(EXA(*!?CA3K7$']HU#]E[9..#C\R`)4:?\"WN&/O":1L&V&HU-=2D#SI
MYUZF/V)#_OG<#0Z/IH<^76S?_,T^)L/S/^&/</3%'20S[V_A"[XZLFD`UTW9
MNR!+F=L0Q.;"-,Z(YL7,UQ^Q7/[@7V^YF/*?-=MNLFKZ0GPI@M*F!_B&:`D-
M1LD#''J:^>N7QS+RQ<[<*?5`:XZ\*KFAH"<YI3U'7S/IH)HC44M7!/1U4+ST
ME72S`PU5'50,\-13S(;-#44TZ%6!Y5U(_'O/UEC=/#J'MW$;$C@5;N%/RZP>
M(D1SVE;F*08/DP-<_EU])K^4W\G9?EC\#.B^Q<I5_?[XV_@).K>QGOJE?>W7
M#1[=JZVHU.9#/N'$Q463):VH5M_>`'N)L(Y:YMO=N"GZ4R&5*>:2G4`.&020
M?*H.>LYN1][/,7+%KN0(\<@HU?)DJ,TKY+7\QUIB_P`ZOY/#Y._/_MBKP^3_
M`(AL+I<P=&;%,4XFHG39$]2N]LI2:#X2F5W]59&TBW\D,,7)`'O+7VEY>/+_
M`"/;>*`+R\)N)1_2;"_LC"_G7K%KW.WT;[S;.4I]+:T@B_TBY-?M<M3Y4ZN1
M_P"$SOQ.FHL/W!\T=T8\))GII>E.I'J:==1PV)JJ/+=F[BHW=?(%KLU'0XJ.
M1+"]#5(2;GW$OW@.9?&O;?E6T8FV@5)I?3Q)!@#[!QK3RZE7V0Y?\*QGYGNU
M_P`8E)AC/_"P00?S/6R9\H_D'LWXK?'SM?Y`;\F1=O\`6>T<CGA0F989\_FP
MJTFVMK4);E\AN?<%334,*@$ZY[_0'W`NS;-<\P;O:[1:`F269032M%\R?LX_
MEU,N][K!LFU3[I.P411DK4\6IV@<*U..OF"=N]K;R[N[.["[D[%R#Y7>_9>Z
M\WO7=%6H=T.2S-4]2U'11\NE!BZ?QTM+$/T4\$:`<>^B&T[98;!MT>U6>+"V
MC4#[4`U'_;4-/4GK!'<=SO-VW&3<[H&2]N)')KQ4.3I"_82*^@!I7KZ!G\F+
MXATOP_\`A+L:CW)14N+[;[G%/W#VHM3+2IDJ#(;DH(#M7:56P<2(NT=I"FA>
M%C^U6S51L"Q]X+^YW-4?,O-]S<HS&RB8QQ=I)TJ36M`1\5?/A3K,?VZV!.6N
M5;>WETK>3*)9,X+$`"E?Z('Y]5N_\*3OB7#O;J[K7YB;,HJ6IW!U%4IUQVF:
M'PR555UKNO)K)M;.57C;R/#M#>=0\#,;Z8<RS&RQ\2;[`<UM'?W7*T[,+>Y'
MC1@@@>,@_4XTXQC%*U(X#H`>]'+C7=E'S';*GCP$0OW"IA)JE`*Y5S4U\N%:
M=:IOQ=^0F[OBC\@^J/D)LC5-F^LMUTF:J,9Y)(X-Q;;J8IL7NS:]7XRI>EW%
MMNNJJ4@W"O(K_5![R&YJY>M>:.7[K9[G!E0:#Y!AD$_G3J".5^8IN7M\MMUM
M""L+D/ZT."!PS3KZ@?5O96T.Y>MMB]L;`R29C9/8VU,'O+;&20J?N</G\?!D
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M1@-=VY6:,>I4]P^TK@=`/VSWIMDYN@F8@6LJM&_V-\-/L;/6^K_,,^3E/\0O
MASWIWHL\46X-O;1JL+L"*215%?V)NYQMK9$,(#:I1#FLC'52!>?!`YN!R,-N
M2-AFYIYDM=H*T22<^)7@(T;4Y/'BN%]3C'657.F[IRWRK<;BC#QO!*1?\U&2
MBG[*Y_R=?,LQ.+W!NS-XS!XBGKMQ[MW7G*+$XRDB5JG)9_<VX\E%1T<"(H+S
M5N5R]<H^A+/)[Z"W4MK8PRW3,8[""%F`.`0B`*&^>#3K".-;C<;E((TUWEQ<
M+D<5UGN(^7KU]/SX2?&;!?$#XL=,?'W#+#)5[%VC1INW(PHBC.;]S!?-;XS;
M,H_<&1W-75!C)N5@6-;V4>^>/,N]3<P[_=;W*.Z>1B`?P)4T`X\`!UG7L&RP
M[!LMOL\)[8$6I'XVIDG[3GJH7_A1!\T?]"7QLQ'QCV7FA2=D?)8UE+N:.EF*
M5^&Z4PDZ#<]2S1,)*7^^F9$&)B)(\U**T#]/N4?8SE6+?N8/WY?(QVZS%4!X
M--Q0?8.)_+J-O>3FD;5L`V2S<'<+P]P'Q"(8;\Z\.M2KX$?%G)?,GY9]/]"4
M\4@VYG]P1YSLC(JPCBPW5^UBF7WM62U!LE/+68N#[&F)^M961*+D^\DN?>:D
MY4Y7NMY9M&XZ"L2@$GQ6.E33^$,:GB=()H>'6/W)/+DF_P#,EOM:J3MP<&5F
MP/"458?Z<J*`<-1XTSU]-?'XG;&-P%)M:@I,-2[:H</2[?H\#"](,73X*DH8
M\;3X>.E)\0Q\>/C$`CTZ3'Q;WS\6Y7Q1.2PG\0R:@K5UL:L>`XG->LVW2U,(
MME*"&FEA490"@''T_P"+Z^:G_,H^*C?#?YE=R=.8^DEAV&^=?>_4]0S+)!4]
M:[R>7*X*EIYT_;G.VZEZC$R6Y$E";_7WT%]O^97YMY/MMWF;5>CLE]0RXR/G
MQ_/K!SG;EVWV#F>YVV,4LU8-'\P<]7D_\)KOF<<1N+L/X0;VRP%#N1<AVQT@
ME9,1HSU+#$G96SZ!I#I`R..A@S%/`I'KIZUP"6]PI[^\M-XMKS7;*6.I89J>
M2@'0_P#I14@FM>``/4S^R'-1D:?EJZ(71WQ5\RWQ`9SUN!L0!S^>..22>``/
MJ2?>-1(52[&BCK(95+MI%*]:%O\`PH)[\^-O='R]QF#Z5V_05_8/4^!K=C]Y
M=O8BI08W>FY*2IIUQ6RA#3J:?-5O6D<4]-/E2Q<RSM1`LE*",RO9'9N8-HY:
MDFWAF6QN:/;0-6J*227(/PB3XE`K4=QI7K$;W;WG8=WYD$>W*&FMP4FF6G>X
M%`H-<Z/A8FG"@K3JAC\?[ZU_<S=1+UO-_P#"=;O7XX;G^*-?T;UYM[&;#[UZ
M]RU7N#NC$35RU><[.FR]2L.,[<HZNH6*KKL))2"#&/2*&CPTU.L(`2:-Y,./
M>[:M^M^;CN>Y.TFV314M^.E$_@X88'4?G7CUEK[.[QM%[RPNVV2JE];M288U
M._'4,Y6A&?EUL/\`N%NI<Z][]U[KWOW7NODT;N_X^_=?_AS9_P#]V]7[Z3V_
M^XL?^D3_`"=<]I_]R9/],_\`S]U]&W^3K_V[%^&O_B*F_P#>JW'[P/\`<L:N
M>]U7UNW'^#K-CV^_Y4K;/^>1/\'6NU_PHH^!"]8]F8[YN=9X3P[%[>RM%MKN
MJBH8=,&WNUOMC'A-YS+&@2*B[#QU)]O52'C^+4H9B7K/<Z^Q'.O[QVUN3]P;
M5?68K"Q(!:*H!0<"Y!((XG3@<#U"GO1RHUA>KS+;@"TF.F0`85Z$ZB?(&GG0
M5_+J@+JKOO??4>RN^.N]NU*3;+^176J=;]B8&KDD^SJH,;GL=N;:^XJ5%N(\
MYMC,8]O`]AJIZJHB)M)<37N?+]ENM[9;H1_NPL92R/7*U!5T^Q@<CU%>/43[
M9O=]MEA>;8%U;?>QJ'!/'31E(\UH:'%*^=:]);I[_F</4/\`XECK7_WML'[=
MWO\`Y(M__P!*^X_XZ.M<M_\`)>L/^>Z#_CW7TV/FS\?(_E5\5N_?C]Y:>GR'
M9?7N=PVW*NKL*6AWC2B/,;-KJER"8Z>DW1C:1I&'(C#'W@%RIO)Y=YELM]`)
M^GE&H#SC8T<4^:UZS5YIV;^L/+UWM`IXDT1"GT<90_D?R]>OF`;IVKN38VY]
MQ[)WEAJW;N\-G9W*[7W5M_(Q-!7X3<.#K)<?EL95Q,`5FI*R!EO]&6S`E6!/
M0JVN(KR".[MR&M98D=6!J#J%<$8/E7TZP9O+62TNI+612LD3E6!!!!!I4@Y%
M?+K91_D7_P`V3J_XT;4RGQ*^3VY1LSKJLW36[HZ@[-R$-1-MK:F2W+*)MT;*
MWG501SRX3"9'+WR&/R#)]K!45%3'4-&C1O[QY]X_;/=-VO7YMY=3QIS&HG@_
M$-`"B1?-B1Q5:_9U.GM1S_MVW6*\N;Z_@P1NQAF]2Y),;"AH%)PQI7UZW`]O
M]Q]0[KPT&XML=J];;AP-3`E5!FL+OO:N4Q<M/(NM)5KJ+*S4V@IS?58>\:IM
MJW2T?PKNWFCF/DT;K^RH!/60D.Y;;*E8;F"0#BP=#7]AH.JG_P"8_P#SE/CC
M\4>L-Y;8ZA[(VEVU\F<SA*_$[%VIL?*T.[,+LW-5L;4D.[>P,[AYJO#XBBV[
MY#5)0-,U;73Q)"(D1WECD;D/VPW[F:^CFW&![;8D<&25P5)7B%56H6+4`J`0
M*U)Z`?.?N-M7+MA+%921S[RRTC1&#`$X)9A4#2*FA-<4Z^?G4U%35U-375U3
M+65U=4U%=7UM0Q>>MKJR9ZFLK*AR3JGJJF5Y'/Y9C[S9142D4>$H%0>H50HQ
M]@ZPZ>H!DDXU+.?(%F).?SZW9O\`A-O\4\YU;\>^R/DUO'$U&*RWR-RV&QVP
M(*V%H:F;JC8G\16CW`D;^N.CW9NG*UDE.6`\U+1PS+=)$)Q&]]^9K?=N8X]C
MLO[#;U8-FH,CD$FOY<.LK?9GE^3;.7VW:X4B2]*E*U!")4`$?GYYZV3P2""#
M8CZ'^A_!_P!A[@HBH(&#3J8@0N3P'7SPOYWWQ,3XL_.S>];M[&#']:_("ED[
MKV2M/#XZ"CRN=R%13]B[?I2JB.,XK>*2U2Q#_-TN1@``%O><'L]S,W-')L;2
ML'NK(K;L<5*JO8QI_1P3YFN3UAM[J<O#E_FN1HQ2WO:SKQH"30J#PK\O3/0D
M?RFOYE`^$W27SEV1F<J(I<[U1-V9T;CZB3T2]XTXI.OX<911G@R92FS^.R$R
MBUZ?"2M^#[+/<SD*3FGF+9;^%?\`%Q+X5S3_`'TI\2I]/,`\:D#HR]ON<SRY
ML.ZV<DE*PF2`8Q,XT5%>/!25R,<,GJF/9FT-V=H[VVOL+;<-5N'?78VZ\1M?
M"1-KGK,QNK=V6@QU-),1JDE>JR=?Y9G-R%+,2;$^Y3W"Z@VC;);]Z)8V-NTK
M`F@\*(96IX$U%#QQU&%I9W6\;I':P$F]N9P2:5KGOQY8].'7U$OBST!M;XK?
M'?J'X_[06/\`@_5NR,3MR:M1='\:SBQM6[HW'.#8_<[BW)5U5;(3SJFM]![Y
M[;[N\W,.]7.]WC:I+F36?(!14H*"@`"T&./GUGQLFUV^S;9;[/;+IMX450./
M`>O$Y]>M57_A2/\`-5=W[_V5\(MCY9I,%UI-C^RNZ#23`T];OO*X_7L7:548
M[B4;7V[7/DYXR2!4Y&GN`\`MDA[!<K_2V4G-UVG^-3#1!J\H\AV"G^(T`;T4
MT\^L=O?#F-+R=.5K9B!"=<E#Q?!3-?PBM1\\]:UNP.J.U.UZS)4'5?6?8/9F
M0P]-#6Y:AZ^V=N'>%9BJ.IE>"EJ\C3[?Q]?+0T]1/&R1O($5W4@$D'W/MY?V
M&V1AMQGB@0C'B,JU^P.1J_*O4)6-EN5_)2RAGN)Q\7A+4U\^`*K^=/ET,A^+
M/S?/_<N7RU_]%?V__P#6CV0G>.2":BXVY2>-%@%3ZFG$_/H__=7.E`/I][H.
M`U&@'H/0=89OBC\V*F*2GJ?C7\KJFGF4I-!4]4=M5$$J$@E)89<,\<B$CZ,"
M/:F+?^3E92+RQ3PP:$>"I%>.00?Y]--LG-;"CV6YT/\`'J*G[:9)Z`'=6T]U
M[&W!DMI;WVQN+9NZ\+)%!F-L[KPV1V_N#%33T\57!'D<1E8*6OI'FI*B.5!)
M&I:-U8<$'V>V]U:7<8N+"19K<\&4@@D>A%0>B"ZM+BSE,%U$89AQ4@@Y\R#D
M'[>MOS_A-K\TCN;9.^OA#OG-F3-=>+7=E=)1ULJZZK8>4KD_OSM2CDE?4YVO
MN6O3(01+<BFR4MK)`;8L>_7*+;?NL7-5LH%M=BDM.`E.02/PU`I3`J/GUDM[
M*<SR7NV2<MWCZKBU/Z5:`^&/(>;4)XY/SZO>^>WQ=QOS)^)7<WQ_JUITR^[M
MKSUNQLA4Z0F&[%VXZ9[8V5#M;QQQ[@H(89S?FFFE'T-O<0<E<P3\J\UVF_Q/
M6&-M+K0$:&PQX9[22/F!U)_->Q)S%R]>;3,*&5:H>)U**C'ED4^>>OF)97%Y
M+"Y#*X3,4M1BLUA<AD<-EJ&75#5XO,8BLFQ^2I)`0&BJ\?D*:2,_E73_``]]
M!H9X+B!7TB2QN8-2-7X@PH,>GG7K!:6&>"9D0Z;BWG"L?/4IJ<=7?_S+_P"9
ME4?+OX:?`[INAS!J-P8W93;Z^1M/#(PU=G[(:NZMVS19!&&KRUT&/R>?"W*F
M/(TL@YM:&O;GV\DY8YEWC=;[M7Q1%`:`UC8B0Z?E4A2P]".'4N>X?.Z<Q[!M
M6VP-_:0>-)3R:,E:-3@3IJ`:8/#J;_PGW^)O^G[YK4_<.XL3]]UY\6L7#ON=
MZB)VHZKM/.&IQ?65!?B.6;$215V9TG]$F.A8_47M[X\R_NCE1-DB:ES?W"@T
MI41H"6KY@-J&>K>R_+YW/F0[O*M;*T3SX%GKIH>!*Z>'[>M\S.9K$[8P>8W'
MG\A38C!;>Q61SF:RM:XBH\9B,3239#)9"JD)&BGHZ*G>5S^%4^\.;>*2>1+:
MW4M.[!57S)8T`^TUZRI:58K=KBX("(I9B>`H*YZ^9/\`S`?EKF?FU\LNUN_J
MQJB';.;RB;=ZPP]1K5L#U;M@RX[9M&T+'3#69.DU9*L``O6UTM_I[Z`\B<L1
M\H<KVNPI0W:@22D"M9&`([LZJ#%*TQ3K!?F_F&7FCF"YWMV/TSDI&#0:$7!'
MEQ.:\>@JV=\</E#NS!X[>/7?0GR`W)MO.4SS8C=>Q^L^PLEA<S1I420228[.
MX+$24>0I5JJ=D8QRNFM"/J/9G?;SRIJ-M?7=I]3&Q)5S$65B<U#&H\QD=4M-
MEYF5!/8VM[X;HM&AU@LM,$'AD9)\^E7_`+*S\W_^\<OEK_Z*_M__`.M'LM_>
M_)7_`"E6'[(.EG[JYT_Y1M[_`-Z/27W9\:?E/MS"Y/=^_?C]\A<%MW;]"]9F
M=T[RZQ[%H<-@\9$X\M5D\UFL.E)C<?$\EV>21(U+7)]F%EO7+<D@M-MNK36Y
MQ'&8EU'Y*I%3^53TAOMHYA6,W.X6>X!%XO*I8#[32O[<=)'ICMO>?0G;/6_=
MG7E6*/>O5F\<)O3;SN2(*FKPU6LTV*K54CR8W-T1EHZE#PT$[C\^U6];5:[]
MMESL5VE4GA:-JU&&R*'&E@0#44(Z2[/NEUL6YV^]VST>!ZK0`X/Q57(:HX5K
M\NMOG^:!_.]VA@_BOUKMSXF;F#]S?*+J[$[SK<_CZJ-\AT)U_N:EDI<H*N2(
M$T?9U;70U>-H(6`DHE@FK6"G[7R8O>W'M-<W7,DUUS2ACV?;;@)I()$\@R`!
M^*.@+$BJ\!Z]9%^X'N?;1<OQV?+3^)NM]#JU`@&&,X-2#VO6@`/=2IX=:B'2
M72_8WR.[<V)TGU5B)MR=B=E[ABP6"I9II#"L]1Y:O)YW.5TA=Z;#X:ABGKLA
M5R$F."*1R2U@<FMYWJPY=VB?>=T<I9VWPJ!\8`JB#T!%%QPZQXVC:;W?MVAV
MC;D$EY<98UIHSWN?7S8D\>K]/YJG\DG&_$[XW=9][?'MLKNRBZKV;BMM?)^.
M:6LJ\AF<DTRM4=Y8NBF>7^&85<O7/1Y&@A`BH<>*2<"T55(8;]N/=M^9-\FV
M??V$3W$A:U(50`O^^F(XD"A#')-0?+J6/<'VO38-HBWG84\2WAC`N068G5_O
MQ:\*G!48'EU1'\<?D/VC\5>Y]C]\=-YM<+OK8N1-52"?7+B,]BJI/M\YM3<5
M+&R_?;<W'CB]/51WU*K"2,K+'&RR]S+L&W\T;+)M.ZH&A:I4_B1N`92,X.:<
M/EU%.Q;Y?<K[NF\;7F=*52M%D7B5;RR//C\^OI*?";YC]6?.7H+:W>?5]48$
MR`&'WMM&LFC;-]?;]H:>%\_L_,1KI+M1R3K+1U(41UU#+%.E@Y5<#N9^6MRY
M2WJ79=R'ZBDE&\G0\"/L''S!P?7K-OEWF#;^9MM3<MK;Q+=E&H^8?\2D?T>%
M>!\CT;?V'Z@Y'#H\X\.O>_=>Z^;/N;^53_,@JMS;CJZ;X9]V3TM5N#-5-/-'
MAL24FIY\G530RI?,@E9(W##_``/O/2W]R/;\01QR;M;J0J@X8T(`XT^SCUA1
M<^W?/(EDDCVV5AJ8X*BH->%?MK3K>B_E==<;\ZB_E^?%GK3L_:F8V-O_`&?U
MRV*W3M+/PQT^8P62.XL[5?9U\,4L\23?;U,;^EV!5QS[PVYYW"UW7F[<-QL6
M#VDURS(PX$&F>LL^3K"YVOE>PV^\73=16R*P]"!D=&;[YZ3V'\C>G.QNC^S<
M9'EMD=E;7R6VLW`T:234GW<):@S..+@^#+X')1PUM'*+-%4P(P/'LDVO>+O8
M-R@WFR<I<V\@<$?;P/R(X]&6[[5:;[M\NSWR![:X0J:^6*@_:#U\]SLO^3E_
M,4V#V%O79.$^,W9G9>#VON3*8;!]A[1QF-J-M;VPM)4NN)W-AWGRL,Z4V7QY
MCE:*1%D@D9HV%U/O-[;_`'5Y#OK&&\GW"""XDC5G0@@JY'<#\ZUZQ"O_`&NY
MTL[V6U@LY)H(W(1P005'PT^P8ZY=7_RL/YC.([0ZQR^3^''=-%C,3V1L+*Y*
MMGP^*6"BQV-W9B*VOK)V&9)6&EI('D<@&RJ?;.[^XW(<VU7<$.Z0--+9S(HS
MEF6@_GTHV7D'G.TW>TN9]OF$,=U$['&`C5/7T?G(=G(Y5F8C_$$FQ_KR/>"H
M[UH:C)'SXD=9C5916.FKB*\/SZHY_F=_R5NL/G1D:ON/K//XWICY(+1)3Y/<
M,F)>KV3VC!1Q+%CX>PL=CPE?39VC@00PYJE$M0(0(YX:A4CT2[[=^[.Z\EQK
MMNXZKK8*GMKW1U\XZX`\R,9X$=1CSW[:6'-;G<MOI!O6D\,+(<4U4SCR/SSU
MJ6=Y?RBOYB/060K:?<WQGWSO;"TID,>\.GJ4=J;:K*9&(6JC_NL*G<%$DB@'
M168^FD%[%;@^\D]E]TN2-YB0PW\<<[#X9>PU\ZDX_,&G6.N[>W'.>T:FGLWF
MC7XFB[A^0XG[.B55/07=F+JFQ]9T3W%0U4C,)*2HZGW]32E^2RR4\FW5=FO]
M1;V+3O?+DX$G[QV]OMDA:GYN<?ET&6V??+;M-C>K7TCE7_CO^7/0T=7?`#YM
M=P5<%#UI\3>],Q'42+''7U/76<VG@(M9L)*G/;NIMOX*DA!/+O.H]E^Y<[<E
M;3&7W#=;4$#`0^*Q^05*_P`L#HSL.2^;MS(^AVVY()XNOAJ/M9_\N3UL'_`W
M_A.-N-=PX#LGYXYW`1X#%U-/DX_CUL?*R9F;/S4[B:GH>QM\T@IZ"GPQD4?<
MX[$F=ZE08VK$0L&@7G7WTBO+63;.3E<*_:]PZZ67_FB/B4^K&GV=3-RG[*F*
MX3<.:V5C&=20(U4)I_HODPKY#[>MN7$XG%X'%XW!X/'4.'PN&H*/%8C$8REA
MH<;B\9CZ:*CH,=CJ*F2.GHZ&BI84CBBC54C10%``]XX,S-(\LC.\LC:F9C4D
M_;UD#%"D(T1C3$H`51A0/L_P=.'NO3I`(H>'5+7\\OX/[H^8WQ*I<GU-M&IW
MAWKTENRBWAL3!XJ**3/;GV[F33X+?NT,5YI((I*FMQSP9&*)I%5Y\6J\%O<K
M>SG-MKRCS.!N$G@[)<J5E_A4UU*U/0&H/V]1I[I\KS\R<N$[?'XF[6Y!C`XD
M4II'SZT\#_*@_F3$_P#9%W=W'T_W"XG_`%O^=UQ[RD;W,]OB6(W:`BI\F&*X
MP>L</];CGA]);;95)`KD&AIG(ZN+_DB_RKOD)L3Y?'OCY4]&;OZMV]TIM>JR
M_7%+OFAH(/[R]F[D\V#QU;CH*>LK6DBVA@GK:IY#I\=5+3$7(-HE]W?<;9-Q
MY<79N6[M;@W4E)]-0!$M"5-?XSP^PUZE'VL]O]UVS?VW;?[=HO`0>'7B6:H:
MGV`#]O6V]W)O/<O7G5/86]]F[$SO:&\-L;1S>6VIUYMFG6IS>\]RTU'(<%MZ
MBCDEA1?XEDVC261F588-<A-E]XV;;:V][N$%I=RI!:22JKR-\*)6C$_8OEY]
M3WN%Q=VFWS7%K&TUZD;%$6E6;R`KCKYY'8O\N+^:MVUO[>G:/8/Q$[USF^.P
MMSYK>.[,M/B<7+)6YO/5TU?6F,OG&*4D#R^*GCOIB@1$%@H'O.&PY]]LMMLX
MMOL-R@CM8$6-`0<1J**,>8R3]O6(6Z<C>X.YWLE_=V,KW$KDDU'"N!^76W+_
M`"/_`(+9SX7_`!4GRW9VUZG:_??>6=_OCV-BLE'#'FMIX3$_=8K8NQ*UH)9T
M27$XTS5U0BR,BU>2D7^P/>+_`+L\X?UOYJ8V<AEV6UC"Q'R)P"P'HWEYTZR"
M]L>5I>6.7%^I0)N<\I,HID`5HI^8]1QZN@\DG_'1_P#DIO\`BON,>I)Z]Y)/
MR[_\E'_BOOQX4H"#Z^G7O.O6JS_/V_EF]P][]G]5_)7XO]3Y_LW=^>PTO77<
MFV]G4M+/FI/[OPO6[$WO4PU572+/"F-:IQ55("740T2VT\C(KV6]P-EV6QN=
M@YFN?`L$_4A>F0S4U**?97\SU`GNUR%NF]7UONG+\'C2R'3,H(!HO`U.*9IU
M3'\8_A'_`#6/BG\@.J?D+L/X7]YRY_K#=M#G9,8F,Q,,6XMO2"3'[LVI6-_&
MP#1[FVW5U5&]^%:57^J#W*7,_-GMIS-L%ULUSNMOJEC/AFC460?"Q^S/[>HY
MY=Y6]PN6M[M]WMMNF*QR#6`14QGX@/Y?LZ^A1M_+/GL%ALX^*RF!DR^+H,F^
M$S=/]GFL,]?20U;8O+4@=Q2Y/'--X9XPS!)HV`)`N<)I8PDC0*054E01P(&`
M1\CQ'67Z.6197!#,H8@\17)!^8X=:4O\X#^4M\E,C\U=\=H?%?H+>O:'6O=M
M!1]E9A]BT%!44>U.R*^6>@WWAZN*>MH6ISFLE1IF8]*LK-D)!>ZGWEE[6^YW
M+L?*<>V<RWB6^Y6C^&I>M#$!V@>>/\G6+ON)[;;\W-$M[R]:-+MMROB-IIB4
MG-?M'57?_#4'\R9;G_9+N[_ZG3A,22;#^G\:Y-A[D9?<KV])`;=;?3^?^;H#
M/[<\\*A;]VS-C@"*GK=<_DV_#++_``N^%NU-L[ZP38'N'M#+5O:?;&/JHX5R
MF%S6:B@HL#L_(21/*&EVEMFAIH)$#LB5;U&GAKG$/W+YK7F[FR>_M23MD8"1
M5\P.)_/C]E.LI?;WEI^5N6H=NN%`O&[WIY%N"_:OGTB_YV<ORMW;\3WZ#^)O
M3?8_9^Y.\LL=O=C9G8E#3SP[3ZNQ:Q5V?QU=65%=0F"LWQ5&#'JB%S)0&K#6
M!%U?M,.6H.:?WQS5<QVUG;K6,-4EI!4`X\AQSYTZ0>YHYEGV#]V\LV[S75PV
MER*45/GYYX8ZU$.M/Y.W\PO?G8NQ-E;G^+W:W7NV=U;MP."W+OO<&-Q=)A=G
M;=R&1@ASFY<A/'E9GCAP^+:690J,7D15`)/O*'>/='D>UVF>;;MSADO(H&,4
M:AJEO(`\./6/6V>V?-DNY0Q7]C)'M\DRAV.0%/Q$TZ^B/UGU]M7J+KS9'5VP
ML;'A-F=?;5P6SML8NG5(TH\+M_'4^-H481*B-/)#3AY7M>25F8W)/O!F[N[G
M<]PFW6[;5<W#EF/KJ);_``GK,6WM8[&VBL;8`6\,:H!\E&D4_(#I<>23_CH_
M_)3?\5]M=/\`22W[LO;G9NQ]X=<[UH(\SL_?FV<[L_=&*J/5%D,!N/&5.(RM
M*UPVEI:*K<*PY5K$<CVIL[RXV^[CO[5M-Q`ZNI]"I!'^#I/=VD-_:2V-P*Q3
M1LA_VPIU\[;MG^3?_,$Z][1[#V+L[XR]J]E;/VGO#.X/:/86WL9C*C"[TVM1
MUTB[>W)0RRY2"4C)XAH7E5D5HY]:$>GWF_L_NKR5?;5;W>X;C%%N$D2F56!J
M)*=U:=8;7_MCSG:W\]O;V3R6R2L$92*%:X(Z#T?RG_YDHO;X7=W"YN;83$W)
M_K_Q>N3[,Q[E^W[.JG=K<`XKW4&/]0Z2'VXYX",PVZ4D9I45/6U[_(\_E?9'
MX>=<9'OSO7;<>.^2O;-!]A3[>RE/`^6Z;Z[2HUKM1IHY*B&#=.ZZF!*S,-$Y
M\<24](&/CFUXR>[7N">;=R7:MLD)Y=MB:$$CQ7_C']$&H%?M].LA_;#D"/E.
MQ>_OU_W>W5&8G)B`%`B'R!%"U.)ZOFS&'Q6X<3D\#G<;09G"9K'5N)S&'RE+
M#78O+8O)4TE'D,;DJ&I22GK*&NI)GBEB=2KQN018^XA1Y(I$FA=HYD<,K+A@
M5-10^5?/J3KB".XC,<H#H005;*,"*=P\Z>77SN?YN/\`+CRWP!^0,K;3I:VN
M^.7;55E,]T[G'CEDCVU.DK56:ZIR]6P93EMIB8/0NQU5>):)^9(I].<WM=S]
M#SOM0%V5&_6JA9T%`'ICQ$'H0!J!_%7Y=8:>XW)EURANS-"NK:;@EHG()`K_
M`*&_SK6E/*G0:_RS_P"8-O;^7OW]1;[I!E-P=.[Q:CP?=O7-'.=.X-O),32[
MGPM+(PIDWKLYYGJ*&3TFHB,M([!)KK?W'Y"LN>=F:(#3OT09XI!QQ3].O'2V
M-7Y=5Y!YSN>4-W621V_<4A594'X2:]P\J"I/KU]&[KGL/9G;6PMH=F==[BQV
M[-C[ZV]C-S[6W%BIEFHLKALM3K44E1&0=44JABDT3@203(\;A71@,'+JUN;&
MZDL;U/#O86*NE*:2#0C\CUF;:W-M>6T=[9LK64JAD8&H((J/Y=+3VGZ?Z][U
M0#R'5BS,*$FGV]>)O]?>^J]>]Z(!X]>(J*=>]^TJ.`'5E9E&D$T'SK_AZ][J
MT:-Q'6BS%@Y/<M:?GU[W<"F!UKY]>]^&#J'&E.O>5.NP2/H2/]8D?[R/=71'
M`##M'Y?X.M`:105I]IZY>23C]Q^/]K;_`(KS[WI!]<?,]6!IUP)+?J9F_P!=
MF-O]:YX]^H`=0`U#S\_V\>O`D'_53]G#KWNQ8L:GCUK'D`/Y=>]ZZ]U[W[KW
M7OI[]\NO4KU[WHJIX@=6#,!I!-/MZ]?WI45/A%.J4IZ_MZ][V0"*'AUOKWNH
M1%X#K:LR_"3UW<^[4_EUXDDU/'KKWOK77O?NO=>O[\,&HX]:(^W\B1_@Z][T
M54^73FMSQ/7OK[WU3KWOQSQIUM25^$GKW^^^OOP`!J`*];+LPH2:'KWO0`5=
M(PM?\/5:T4+Y#KW^'O9[N.:=>_&)/Q@4_+[.'7KD?GWX4!J`*_9U;4VH/7N'
M7O?N.>J\<]>]^Z]U[WL&G#KW7O=2`?(?LZL&910$TZ][]0>@ZWXC^O7O=B:]
M4X\>O>]=>Z+!\Q?BCUI\T_C_`+WZ![2IW3#[FIDK,#N*CACES6Q]Y8P23;:W
MG@6D!"Y##5K?N1\+5TCS4[GQRM[/N6>8[_E+>HM\V_,L;#4GE(E1J1ODPQ7B
M.(R.B/F+8+#F;:9=HW`'P7!TL,LC4PZ_,'RX?+KYI_R.^/W9GQ4[IWWT-V_B
M'PN]MA9:2AJ)"K)CMPXB8F;`[NV_-(%%9M[<V+,=52RJ397,;VEC=5SYV#>[
M#F;9X=XVMM=E(.->]9`!XD;`<-!(IZU\^L']YVC<N7]VFVW<T$<R-VCBK1YT
M.":U+#C3'IU=!_(V_FG+\4M_TWQ>[QW%%'\;^U-PF7:NX\M6,*;I?LG,O'`M
M7)4S2&&BZ]WI5Z$R*$+%CZ]UK`522J+1%[P>VK[]9-S-LJ:=[A7]:.,5,D2\
M'7CJEIEAQI7TKU*_M-SS^Y;O^KFYR:MIG:L3L?[.4Y*$?AC%**?L'GUO-_QO
M%?\`.QQ/_GXQ_P#]4>\2]!_@;^?64'C1^J_M'3I[9Z=Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>]'J\?QCK3&_X42_]EH=;_P#BO>W?_>UWK[RV]D?^5,D_Z6$O_'4ZQ;]W
M_P#E:(_^>./_``MU0-6_\`ZK_J'F_P"M;>YA3@__`#3D_P".-U&=I_N7%_S5
-3_CPZV0O>'_65W7_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
